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1. Abstract  
The tetraspan-transmembrane proteins of the M6-proteolipid proteolipid protein family are 
among the most abundant cell surface proteins in neurons. Their cellular function has 
remained largely speculative, also because their analysis has been limited to acute 
alterations of their abundance levels in vitro. Based on expression analyses I have 
hypothesized that neuronal M6 proteolipids have a role in neuronal development. Indeed, the 
results presented in this thesis show that M6A defines an F-actin-free structural compartment 
at the tip of axonal growth cones while its homolog M6B is mainly present at actin-rich 
neurite domains. For the analysis of neurite extension upon chronic deficiency of M6-
proteins, single-mutant M6Anull and M6Bnull mice and M6Anull*M6Bnull double-mutants were 
characterized. Importantly, lack of either neuronal M6-protein impaired the extension of 
neurites from cultured cortical neurons ex vivo. Mutant growth cones showed abnormal 
compartmentalization and did not display normal growth cone collapse upon ephrinA5-
application. The mechanism of action is likely to involve Eph-receptor signalling, as the 
abundance of the effector molecule ephexin-1 is considerably reduced in the absence of M6-
proteins. Preliminary analysis shows that the formation of neuronal processes is also 
impaired in vivo, at least affecting the long-projecting cortical neurons traversing the corpus 
callosum at an early postnatal stage. Together, M6-proteolipids contribute to the structural 
organization of neuronal growth cones that is prerequisite for normal reaction to guidance 
cues and neurite extension.  
 
The third member of the M6-proteolipid proteolipid protein family, termed PLP, is the most 
abundant protein of CNS myelin. It has been surprising that myelin biogenesis is not 
obviously impaired in PLPnull mice. In a candidate approach the structurally related tetraspan 
tetraspanin-2 (TSPAN2), a known low-abundant myelin protein, was identified as a candidate 
to compensate for PLP-deficiency because of its considerably increased abundance in 
PLPnull myelin. To investigate the role of TSPAN2 in myelination, I generated TSPAN2null 
mutant mice by homologous recombination in embryonic stem cells and TSPAN2null*PLPnull 
double-mutant mice were bred. These mice are viable and fertile. Interestingly, the initial 
examination shows that the abundance of the closely related tetraspanin CD81 is increased 
in TSPAN2null myelin, signifying a molecular change that may compensate for the absence of 
TSPAN2 function. Considering their spatio-temporal expression and that overexpression 
studies hint to a role of TSPAN2 and PLP in oligodendroglial processes formation it is likely 
that tetraspans of various protein families have overlapping and partially redundant functions 




All our behaviours are orchestrated by brain function, which is performed by neurons and the 
connections between them. The proper performance facilitates a very complex behaviour. 
Brain function enables simple motor activities like breathing, smiling and walking, but also 
very complex ones as emotional and cognitive activities like feeling, thinking or writing a PhD 
Thesis (Kandel et al., 2000).  
 
The cellular unit of the brain is the neuron. At the end of the nineteenth century, Ramón y 
Cajal proved that the nervous system is a network of single cells, leading to the “neuron 
doctrine”. He demonstrated that neurons are the basic signalling unit of the nervous system: 
each neuron is one defined cell, which contacts other neurons at specific interaction points, 
the synapses (Ramón y Cajal, 2008). There are two distinct classes of cells in the nervous 
system, neurons and their glial support cells. In the human brain there are about 1011 
neurons associated with over 1012 glial cells (Kandel et al., 2000; Gilbert, 2003). 
 
Neurons transmit electrical impulses form one region of the body to another. To prevent 
dispersion of the electrical signal and to facilitate its transmission to the target cells, the 
conducting part of large axons is insulated at intervals by oligodendrocytes (OL) in the 
central nervous system (CNS) and Schwann cells (SC) in the peripheral nervous system 
(PNS) (Sherman & Brophy, 2005). The OL wraps a process extension around the developing 
axon and produces a specialized plasma membrane called a myelin sheath. The myelin 
sheath is essential for fast nerve conduction. The axon has short non-myelinated segments 
that enable saltatory nerve impulse propagation, called the nodes of Ranvier (Sherman & 
Brophy, 2005). Myelin is indispensable for proper neural function, and demyelination of nerve 
fibres is associated with convulsions, paralysis and several debilitating or lethal afflictions 
(such as multiple sclerosis) (Gilbert, 2003). 
 
The nervous system can be subdivided into the CNS and the PNS. The CNS comprises the 
brain and spinal cord, while the PNS is made up of all the remaining ganglia and peripheral 
nerves. The PNS has a somatic component (the sensory neurons form the dorsal root and 
cranial nerves) as well as an autonomic one (the sympathetic, parasympathetic and enteric 
nervous system). The CNS and PNS are anatomically separated but functionally connected 






2.1. Development of the central nervous system 
After gastrulation the mammalian embryo has three embryonic layers, namely (1) the 
endoderm that gives rise to the gut, liver and lungs, (2) the mesoderm form which originates 
the connective tissue, muscles and vascular system, and (3) the ectoderm, the outermost 
layer that will give rise to the major tissues of the CNS and PNS as well as the epidermis. 
These three layers are part of the neural plate. Inside the gastrula is also the notochord that 
induces the neurulation (Kandel et al., 2000; Gilbert, 2003).  
 
During the following neurulation, the neural plate undergoes the neural induction so that it 
folds until forming the neural tube, which is the embryonic precursor of the six brain regions. 
The neuroectoderm produces neural precursor cells that will give rise to the neurons and glia 
of the CNS. The neuroblasts will migrate into the nervous system and differentiate into the 
neurons of the brain and spinal cord, while the glial progenitors give rise to OLs and 
astrocytes (Jessel, 2000). Cells within the neuroectoderm give rise to the neural crest; a 
transient group of migratory cells that emerge form the dorsal region of the neural tube and 
rapidly disperse along different pathways. They will give rise e.g. to neurons and SCs of the 
sensory and autonomic nervous system (Gilbert, 2003). Cell differentiation depends on a 
series of signals that ultimately control the differential activation of gene sets; each distinct 
cell type expresses a different subset of genes (proved by Monod and Jacob, late 1950s, 
cited after Kandel et al., 2000). In the vertebrate neural development the cell-to-cell 
interactions are essential (Kandel et al., 2000).  
 
Subsequently the organogenesis occurs, in which the rostral segment of the neural tube 
gives rise to the brain and the caudal segment to the spinal cord. The rostral neural tube 
transforms initially into the three primary brain vesicles: forebrain, midbrain and hindbrain 
(Jessel, 2000), and with several flexures (cervical, cephalic and pontine) and further 
subdivision, the CNS is finally constituted of six main parts. From the forebrain arises (1) the 
telencephalon, which includes the cerebral hemispheres that are involved in perception and 
cognition and (2) the diencephalon that contains the thalamus and hypothalamus, integration 
centres, as well as the retina and optic nerves. The midbrain gives rise to (3) the 
mesenencephalon that controls sensory and motor functions like eye movement. The 
hindbrain forms (4) the metencephalon which includes the pons and the cerebellum, related 
to movement modulation and learning of motor skills, and (5) the myelencephalon that forms 
the medulla oblongata, involved e.g. in breathing. The caudal part of the neural tube stays 
undivided and becomes (6) the spinal cord that controls movements of the limbs and trunk 
and receives and processes sensory information from the skin, joints and muscles of these 
(Kandel et al., 2000; Squire et al., 2002; Gilbert, 2003). 
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2.1.1. Neurons 
Neurons are compartmentalized into three functionally different domains: the soma, where 
the cellular metabolism takes place, the dendrites and the axon. The dendrites receive 
signals from other neurons, which are conducted into the axon that transmits the signal to 
other neurons with an all-or-none propagating system, the action potential, a transient 
electrical signal. Axons may have up to one meter length, e.g. the pain sensing cells at the 
toes that transmit their impulses all the way to the spinal cord. The presynaptic terminal at 
the axon’s end transmits neurotransmitters to the adjacent neuron at the synapses (Kandel 
et al., 2000; Gilbert, 2003). 
 
Neurons are the signalling unit and their interconnection allows the processing of information. 
The functioning of the mature nervous system depends on the action of distinct neuronal 
circuits. The neuronal connections are established during development and in the CNS of 
vertebrates it is an intimidating complex system: millions of neurons project their axons 
throughout the brain and establish thousands of connections with different target neurons. 
The diversity of connections by one single neuron distinguishes it from other cells (Tessier-
Lavigne & Goodman, 1996; Kandel et al., 2000).  
 
The neurogenesis comprises several partially overlapping steps that include proliferation, 
migration, cell differentiation, maturation and cell death (Kandel et al., 2000). The migration 
pattern of neurons establishes the basic plan of the CNS. Neural stem cells in the ventricular 
zone of the neural tube divide and form precursor cells, the neuroblasts. These migrate from 
the proliferation site at the ventricular zones of the neuroectoderm to their final positions 
along a scaffold of radial glial cells. Different neuroblasts migrate at different stages, before 
or after extending their axons (Kandel et al., 2000; Squire et al., 2002; Gilbert, 2003). For 
example, in the cerebral cortex, neurons of different morphology and connections are orderly 
arranged into well-defined layers. The layering of cortical neurons is associated to the 
moment they emerged: neurons born at early stages of cortical development end up in the 
deepest cortical layers, and those born at later times end up in progressively more superficial 
layers. Meaning that later born neurons must migrate through the existing layers of neurons 
that have already reached their final position in the cortex. Cortical layer organization is 
thereby an inside-out sequence of neuronal differentiation (López-Bendito & Molnár, 2003). 
 
Once a neuron has migrated to its final position and sometimes even before, it begins to 
extend an axon. The axon extension takes place at its growing tip by means of the growth 
cones (GCs). Ramón y Cajal (1890) postulated that the axon was an outgrowth of the 
neuronal soma and described for the first time the growing tips of neuronal axons and named 
 9 
them growth cones (Fig. 1). In a unique assumption based on morphological observations of 
fixed material he described their behaviour (Ramón y Cajal, 1890): 
 
“Desde el punto de vista funcional, puede estimarse el cono de crecimiento como una 
especie de mata ó ariete, dotado de exquisita sensibilidad química, de rápidos 
movimientos ameboides, y de cierta fuerza impulsiva, merced á la cual es susceptible 
de empujar y franquear los obstáculos hallado á su paso, forzando los intersticios 
celulares hasta arribar a su destino.” (Cited after Ramón y Cajal, 2008). 
 
[Translation of the citation of Ramón y Cajal, cited after Squire et al., 2002.] 
 “From the functional point of view, one might say that the growth cone is like a club or 
battering ram endowed with exquisite chemical sensitivity, rapid amoeboid movements, 
and a certain motive force allowing it to circumvent obstacles in its path, thus coursing 






Figure 1. Growth cone drawings by Ramón y Cajal.  
Growth cones of chicken spinal cord embryos of four days of age, stained by the Golgi method. 
Depicted are growth cones of the gray matter (A), close to the anterior commissure (B) and of the 
white matter (C) (Taken from Ramón y Cajal, 2008).  
Hence, Ramón y Cajal suggested that the growth cones lead the advancing axon to its 
targets, thereby presenting the first instance of growth cones being involved in axon 
pathfinding. Two decades later, Harrison (1909) demonstrated the outgrowth theory. He 
observed living tissue in culture, deduced that growth of axons occurs by extension of the 
growth cones, and demonstrated the truth of Ramón y Cajal’s description of a highly motile, 
amoeboid specialization at the tips of growing axons (Kandel et al., 2000; Gilbert, 2003). 
Shortly after, Speidel (Squire et al., 2002) took advantage of the thinness and transparency 
of tadpole fins and examined living growth cones extending in situ. The pioneering studies of 
Ramón y Cajal, Harrison and Speidel identified the growth cone as the key decision-making 
component in the elaboration of axonal pathways.  
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The neuronal growth cones lead the neuron’s outgrowth by sensing environmental cues 
along the substrate. The force that extends the axon derives from changes that occur within 
the growth cone (reviewed in Dickson, 2002). Growth cones appear as an enlargement of the 
distal axon shaft, where the structural support is provided by microtubules (MT). In tissue 
culture growth cones are flattened into a thin fan-shaped sheet with many long, very thin 
spikes radiating forward. The veil-like extensions at the periphery of the growth cone are 
called lamellipodia, and the narrow cylindrical extensions capable of extending tens of 
microns from the periphery of the growth cone are called filopodia or microspikes. The 
lamellipodia are motile and give the growth cone its characteristic ruffled appearance. The 
filopodia (finger-like extensions) project form the growth cones, are highly motile and 
continually extend and retract. The sensitive capacity of the growth cones depends largely on 
the filopodia: by fanning out in front of them, each filopodium samples the microenvironment 
and sends signals back to the soma. Different second-messenger pathways are activated in 
growth cones by environmental signals and regulate their motility by modifying the structure 
or function of cytoskeletal and other proteins in the growth cone (reviewed in Dent & Gertler, 
2003). Lamellipodia and filopodia of growth cones contain a high density of filamentous (F-) 
actin, and there is evidence that the degree of actin polymerization regulates growth cone 
motility. Actin is mainly present in the growth cone periphery with filopodia containing mainly 
F-actin bundles and lamellipodia an F-actin meshwork (Dent et al., 2010). MTs are also 
present in growth cones, essentially in the axon shaft and the growth cone centre, and the 
regulation of the MT assembly also contributes to the extension and orientation of growth 
cone (Fig. 2). A bidirectional signalling between actin and MT is necessary for coordinating 
their polymerization for the directed axon growth from the growth cone, but is not required for 
axon extension per se (Dent & Kalil, 2001; Dent & Gertler, 2003).  
 
As the axon extends the surface of the neuronal membrane increases tremendously. New 
membrane is synthesized in the cell body and transported in vesicles along MT into the 
growth cone. There, vesicles fuse and are incorporated into the plasma membrane. Although 
the growth cones also recycle membrane via endocytosis, there is a net addition of new 








Figure 2. Localization of F-actin and microtubules in axonal growth cones.  
Scheme representing the F-actin and MTs localization in an enlarged growth cone. MTs are 
present in the axon shaft and the central region of the growth cone and some tyrosinated-MTs 
extend into the lamellipodium and proximal domains of filopodia. F-actin is found in a mesh-like 
structure in the lamellipodium and as F-actin bundles in the filopodia. Note that filopodia are mainly 
formed by F-actin bundles (Taken from Dent & Kalil, 2001). 
 
The specificity of the neuronal connections is one of the most striking physical aspects of the 
nervous system. How do the axons of developing neurons reach their targets? The specificity 
of axonal pathfinding is largely attributable to Sperry (1940s and 1950s), who demonstrated 
the high degree of preciseness in the formation of synaptic connections (cited after Kandel et 
al., 2000). Axon guidance, the directed axonal growth early in development contributes to the 
specificity of neuronal connections, as the axons are guided from their origin to their 
appropriate destiny where they establish functionally appropriate connections with their 
synaptic partners. The selectivity of synaptic connections depends on the recognition of 
specific molecular cues in the vicinity of the target (Benson et al., 2001).  
 
Axons are guided along specific pathways by guidance molecules located in the extracellular 
space (Dickson, 2002). This takes place by the simultaneous and coordinated action of four 
types of guidance mechanism: contact attraction, chemoattraction, contact repulsion and 
chemorepulsion. A single growth cone might be “pushed” form behind by a chemorrepellent, 
“pulled” form in front by a chemoattractant and “hemmed in” by attractive and repulsive local 
cues. “Push, pull and hem: these forces get together to guarantee accurate guidance” (cited 
after Tessier-Lavigne & Goodman, 1996). Guidance cues include molecules that are soluble, 
membrane-bound or from the extracellular matrix. There are four major families of signalling 
molecules that contribute to axon guidance: netrins, Slits, semaphorins and ephrins 
(Dickson, 2002). Many guidance cues are multifunctional, as they can be attractive but also 
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repellent. The growth cone guides the axon by converting the positive and negative cues into 
orders that regulate the cytoskeleton and determine the trajectory and speed of the axon’s 
growth. Axon guidance specificity may depend on the balance between the attractive and 
repellent molecules (Tessier-Lavigne & Goodman, 1996; Dickson, 2002). Therefore, 
molecular gradients help axons to find their correct location within a target field, like opposing 
gradients of EphAs (ephrin receptors) and ephrin-As in the nasotemporal axis in the retina 
determine the final axon’s termination and topographic map of the developing retinotectal 
system (reviewed in Feldheim & O’Leary, 2010). The axonal pathfinding depends not only on 
the guidance molecules per se, but also on their precise spatiotemporal distribution. 
Moreover, axonal outgrowth may be controlled independently of the guidance cues 
themselves. For example, when no ephrin is bound, the Eph receptor recruits the guanine 
nucleotide exchange factor (GEF) ephexin to the plasma membrane, where it activates 
RhoGTPases like Cdc42, Rac or RhoA (Fig. 3). Thereby the receptor without the ligand 
leads to a balance in the GTPase activation, which promotes axonal growth. Once ephrin 
binds to its Eph receptor and provokes the assembly of several ligand-receptor units in a 
cluster, the tyrosine kinase of the Eph receptor phosphorylates ephexin, RhoA gets 
inactivated and acts on the F-actin disassembly (reviewed by Egea & Klein, 2007; Lowery & 
Van Vactor, 2009). Thus, not only the type of guidance cue is decisive for the neuronal 
growth, but also its presence or absence.  
 
Figure 3. Model of Eph receptors, ephexin and RhoA in growth cones. 
The Eph receptor recruits the guanine nucleotide exchange factor ephexin 
to the plasma membrane, where it will activate RhoGTPases like Cdc42, 
Rac or RhoA. When the GTPases are balanced in this manner axonal 
outgrowth is promoted (Taken from Egea & Klein, 2007). 
 
Axons have a non-constant growth rate as they often pause while they project to their 
targets. In decision regions, growth cones change their appearance, become more expanded 
and with a greater number of filopodia (Dent & Kalil, 2001). These changes have been 
suggested to reflect that the growth cone is actively searching for specific guidance cues. 
Once the immature neurons migrate from the germinal zones to their final position, the axons 
will form synaptic connections with a selected group of target cells. The initial synapse 
formation is often accurate, but some synapses are exuberant and superfluous and will be 
eliminated or modified partially during later stages of development, until the mature pattern of 
neural connections is completed (Innocenti & Price, 2005).   
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2.1.2. Oligodendrocytes and myelin  
Neuroglial cells were first recognized over a century ago as connective elements in the CNS 
that fill the space between nerve elements or glue the nerve elements together (Greek, glia 
=”glue”) (reviewed in Zhang, 2001). The three major glial cell types in the CNS are OLs, 
astrocytes and microglia. Many other types of glia cell are associated with them, 
evolutionarily or functionally. Astrocytes and oligodendrocytes both develop from the 
neuroectoderm, whereas the origin of microglia remains controversial, with the majority 
favouring a haematopoietic derivation. It is estimated that glial cells occupy half of the brain 
space, but outnumber neurons by ten to one (Zhang, 2001). Glial cells are involved in almost 
every aspect of neural function. During development, glia cells are implicated in guiding 
neuronal migration (radial glia), removing superfluous cells (microglia), myelinating axons 
(OLs) and forming the blood–brain barrier (pericytes). Under normal conditions, glial cells 
maintain the homeostatic environment for proper neuronal functions by storing energy, 
buffering pH, balancing ion concentrations and recycling neurotransmitters after neuronal 
excitation. Recent findings even indicate a synaptic communication with neurons, one of the 
hallmarks of neuronal identity. Under pathological conditions, glia cells act as a defence 
system collaborating with the immune system and producing trophic factors (Zhang, 2001).  
 
In general, gliogenesis begins after neurogenesis but overlaps with it in several brain 
regions, and persists long after neurogenesis has ceased (Lee et al., 2000). In the vertebrate 
CNS, OLs are derived from oligodendrocyte precursor cells (OPCs), which originate from the 
subventricular zone (Sherman & Brophy, 2005; Klämbt, 2009). The differentiation of OLs 
from their progenitors follows a stepwise morphological transformation from bipolar 
progenitors to pro-OLs bearing multiple processes (immature), membrane sheath-bearing 
mature OLs and, finally, to myelinating OLs. Accompanying this morphological change is a 
sequential expression of molecular markers (Zhang, 2001). The OPCs move as individual 
cells through the neural tube in a saltatory migration mode. Time-lapse imaging of cultured 
mammalian OPCs and in vivo imaging of developing zebrafish have shown that migrating 
OPCs have a rapidly remodelling tip that resembles an axonal growth cone. Interestingly, 
OPCs retract their processes upon contacting another OPC and change their migration 
direction. In addition to chemoattractants that are secreted by the target tissue and guide 
OPC’s migration, such repulsive interactions between OPCs eventually result in their even 
distribution in the brain tissue. OPCs also divide during their passage through the brain. 
Because of the contact inhibition described above, the two daughter cells usually grow away 
from each other. This migration behaviour continues in adults and ensures that brain areas 
lacking oligodendrocytes, such as lesioned areas, can be efficiently repopulated (reviewed in 
Klämbt, 2009). 
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Myelin is a multilamellar isolating membrane that is formed by OLs in the CNS. The OLs 
enwrap tightly the axon with their membranous processes in segments that are separated by 
the nodes of Ranvier. An OL may envelope up to 60 internodes (Sherman & Brophy, 2005). 
The myelin sheath reduces current flow across the axonal membrane by lowering its 
capacitance and increasing its transverse resistance, thereby allowing the fast, saltatory 
movement of nerve impulses from node to node. As a consequence, a large number of 
axons with high conduction velocities (up to 100-fold increase) could be placed in a limited 
space, a feature that permitted the development of more complex nervous systems (Arroyo & 
Scherer, 2000; Poliak & Peles, 2003). Myelin and the confinement of voltage-dependent 
sodium channels to the nodes of Ranvier allowed the fast saltatory conduction of action 
potentials (Hartline & Colman, 2007). In addition, saltatory conduction eliminates the need for 
regenerating the action potential at every point of the axonal membrane, therefore reducing 
the metabolic requirements for neuronal activity (Poliak & Peles, 2003). When the OLs 
ensheath the axon they cover them at intervals (the internodes) leaving bare gaps, the nodes 
of Ranvier (Fig. 4). The nodes are flanked on either side by the paranodes where myelin 
loops form septate-like junctions with the adjacent axonal membrane. The following 
juxtaparanodal domain, as well as the internodes, extends underneath the compact myelin. 







Figure 4. CNS myelination by oligodendrocytes. 
A) In the CNS OLs myelinate numerous axon segments by enwrapping them with several myelin 
sheath layers at the internodes. The gaps they leave are the nodes of Ranvier.  
B) Scheme of a longitudinal section of a node of Ranvier. At the nodes perinodal astrocytes 
contact the axon, and at the paranode the paranodal loops (PL) of the myelin sheaths end up. 
Following is the juxtaparanode that is beneath the compact myelin. The internode is also 
beneath the compact myelin and extends between two juxtaparanodal regions (Taken from 










Myelin is not only essential for the fast conduction of the action potential but also for the 
maintenance of axonal integrity, function, protection and survival. Several mouse mutants 
deficient in oligodendroglial proteins like proteolipid protein (PLP) and 2’3’-cyclic nucleotide 
3’-phosphodiesterase (CNP) (Griffiths et al., 1998a; Lappe-Siefke et al., 2003) show normal 
myelination, but a secondary axonal loss, highlighting the importance of myelinating glia in 
the maintenance of axonal integrity. Myelinating glia communicates lifelong with axons and 
glia is required for the long-term integrity and survival of axons (Nave & Trapp, 2008; Nave, 
2010b). The clinical relevance of myelin is very considerable. Aberrant myelin is a central 
feature of several neurological disorders, including multiple sclerosis, inherited 
leukodystrophies of the CNS and various peripheral neuropathies. Apart from to the primary 
axonal degeneration that occurs in some forms of multiple sclerosis and neuropathies, it is 
the secondary axonal degeneration that seems to be the major cause of continuous clinical 
impairment. Minor myelin abnormalities appear to also contribute to more complex disorders 
like schizophrenia, where patients seems to have myelin and white matter alterations (Nave, 
2010a). 
 
There are several crucial stages during myelination and some of them occur partially 
simultaneously. A first glia-to-axon contact is set at which the selection of axons and initiation 
of cell–cell interactions takes place. After the establishment of stable intercellular contact the 
spiral enwrapping starts (with up to 50 membrane layers) and the nodes of Ranvier are 
assembled. Subsequently, a radial and longitudinal expansion of myelin occurs and myelin 
thickness is regulated by compaction. The glia-to-axon support will last lifelong (Sherman & 
Brophy, 2005). Myelination has its onset in humans around the forth intrauterine month and 
continues in the postnatal period, until nearly all the fibres are myelinated the moment the 
child starts to walk. Nonetheless, myelination is maximal at five years of age and still occurs 
in the fifth decade of life (Snell, 2001). In mice e.g. myelination starts early postnatal, making 
it an advantageous and excellent model organism for studying myelination. 
 
The CNS myelin has a particularly unique composition in comparison to other plasma 
membranes. Some myelin proteins are present in high abundance (Jahn et al., 2009), 
although the complexity of the myelin protein composition may not be below that of other 
membranes. Another prominent feature of myelin is the high enrichment of lipids that 
constitute about 70% to 80% of its dry weight (Norton, 1984), in contrast to most plasma 
membranes that show a lipid to protein ratio of around 1:1 (cited after Saher et al., 2011). 
One of the most abundant ones, cholesterol, has been shown to be rate-limiting for myelin 
membrane biogenesis (Saher et al., 2005). 
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The formation of myelin sheaths correlates with major changes of the gene expression 
profiles of differentiating glia in the CNS (Nielsen et al., 2006; Dugas et al., 2006). Only few 
ultrastructural features of compact myelin have been related to specific myelin proteins. 
Myelin is structured in compacted, concentric layers with a periodic ultrastructure. The 
compaction requires the abundant expression of structural proteins, such as PLP and myelin 
basic protein (MBP) in the CNS. Proteome analyses have revealed that the diversity of 
proteins in myelin is much more prominent than thought (Taylor et al., 2004; Vanrobaeys et 
al., 2005; Roth et al., 2006; Werner et al., 2007; Dhaunchak et al., 2010). A recent 
quantification of myelin protein abundance based on mass-spectrometry demonstrated that 
all the previously known myelin proteins account only for 35% of the total myelin. Thereby, 
65% of myelin corresponds to novel identified myelin-associated proteins. PLP and MBP that 
were thought to comprehend ~40% and ~30%, respectively, of total myelin protein, represent 
a still very high 17% and 8% of total CNS myelin protein (Jahn et al., 2009). The function of 
the recently identified myelin-associated proteins is not well understood. A fraction of these 
proteins may reflect intracellular biogenesis and transport of myelin components that have a 




The proteolipids received their name because of their high hydrophobicity (Folch & Lees, 
1951), as a protein fraction that was isolated from white matter and that behaved like a lipid, 
being insoluble in water but soluble in organic solvents. The protein family of the proteolipid 
proteins includes the major CNS myelin protein proteolipid protein (PLP) and its smaller 
isoform DM20 (Nave et al., 1987), as well as the homologs M6A and M6B. All have four 
transmembrane-domains (Popot et al., 1991) and share a high similarity and homology at the 
nucleotide and amino acid level (Yan et al., 1993). The proteolipid PLP/DM20 is expressed in 
OLs, M6A in neurons and M6B in both neurons and glia (Yan et al., 1996). PLP, M6A and 
M6B are among the most abundantly expressed genes in brain (Huminiecki et al., 2003).  
 
The phylogeny of the proteolipids shows that orthologs do also exist in invertebrates like in 
the bilaterian groups of the platyhelminthes, molluscs, annelids and nematodes. They are 
also present in arthropods like the fruit fly Drosophila melanogaster (Möbius et al., 2009). It 
has been recently shown that the Drosophila M6, the only proteolipid family member present 
in Drosophila and ortholog to M6a, is essential in the follicular epithelium maintenance 
involving membrane remodelling during oogenesis (Zappia et al., 2011). In vertebrates PLP, 
M6A and M6B emerged in an ancestor of cartilaginous fish and are present in all non-
mammalian groups (reviewed in Möbius et al., 2009).  
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2.2.1. The oligodendroglial proteolipid protein PLP 
The proteolipid protein was discovered in a brain protein fraction isolation that behaved 
similarly to lipids (Folch & Lees, 1951). PLP is a four transmembrane domain protein (Popot 
et al., 1991) of 30 kDa (Nave et al., 1987), with two extracellular loops (EC), EC1 and EC2. 
There are two disulfide bridges in EC2 that are essential for the proper protein function 
(Dhaunchak & Nave, 2007). DM20, the smaller isoform of PLP, is produced by alternative 
splicing and has a 35 amino acids deletion in the intracellular loop, resulting in a 26.5 kDa 
protein (Nave et al., 1987). As previously mentioned, PLP is the most abundant protein in 
CNS myelin (Jahn et al., 2009). 
 
DM20 mRNA transcripts are expressed before the onset of myelination (Timsit et al., 1992). 
During the OL development, the expression of DM20 decreases and PLP’s increases largely, 
so that the presence of PLP defines the mature myelinating OL. In the myelinated CNS, PLP 
is found in the compact myelin sheets (reviewed in Griffiths et al., 1998a). This indicates a 
role of PLP in the early development of OLs as well as in myelination itself. It has been 
recently shown a novel function for DM20 in increasing filopodium formation by 
overexpression in COS7 cells (Fernández et al., 2010).  
 
PLP binds cholesterol and this is very important for the association of PLP with lipid rafts 
(Simons et al., 2000; Krämer-Albers et al., 2006). Lipid rafts are cholesterol- and 
sphingolipid-rich membrane domains that form platforms for concrete proteins and regulate 
thereby functions like e.g. intracellular membrane transport and cell signalling (Simons & 
Ikonen, 1997; Simons & Toomre, 2000). When PLP cannot bind cholesterol the proper 
sorting and assembly of myelin in OLs (Simons et al. 2002; Krämer-Albers et al., 2006) is 
distorted. PLP is as well palmitoylated and this is required for the sorting of PLP into myelin 
(Schneider et al., 2005). 
 
Since long PLP/DM20 has been proposed to act as an “adhesive strut” in myelin (cited after 
Kirschner et al., 1984, in Kitagawa et al., 1993), even though there were no indications for 
them being adhesion proteins. The analysis of the PLPnull mice at the ultrastructural level 
illustrated an altered membrane compaction in CNS myelin (Klugmann et al., 1997; 
Rosenbluth et al., 2006). But recently, it has been shown that this has been probably mainly 
a fixation artefact, to which the PLP-deficient myelin is particularly vulnerable. So, X-ray 
diffraction analysis on optic nerve of PLPnull mice suggested a normal compact myelin 
periodicity (Yin et al., 2006). Additionally, high-pressure freezing and freeze substitution, in 
which the in vivo morphology is better preserved, on PLPnull optic nerves has also not shown 
an altered periodicity in myelin (Möbius et al., 2009). Thereby, the suggested role of PLP as 
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an adhesive strut in myelin is still under debate. But PLPnull mice do show a progressive 
axonal degeneration, mainly in small diameter myelinated axons (Griffiths et al., 1998b), as 
well as an impaired fast retrograde and anterograde axonal transport (Edgar et al., 2004). 
This axonopathy demonstrates the importance of PLP in preserving integrity of CNS axons. 
The neuroprotective effect of PLP on CNS axons has also been proven when exchanging 
PLP and P0 in CNS myelin (Yin et al., 2006). P0, the major PNS myelin protein was 
evolutionary replaced by PLP in the CNS. All in all, PLP by its abundance, lipid-binding 
properties and axonal protective effects, does contribute to the proper myelin formation and 
maintenance.  
 
There are several natural Plp1-gene mutations that cause different degrees of 
dysmyelination. The rumpshaker mouse (Schneider et al., 1992) has a point mutation that 
leads to an amino acid substitution and shows a mild affection with tremors. But, e.g., in the 
jimpy mouse a point mutation at a splice site (Nave et al., 1986) leads to a deletion and 
thereby to an altered C-terminus of the PLP protein. The jimpy mice have a severe 
dysmyelination and die prematurely (reviewed in Griffith et al., 1998). The pathology of these 
mutant PLP mice is due to the toxicity of the misfolded mutated PLP protein (Klugmann et 
al., 1997). There have also been generated two-fold overexpressing Plp1 mice that show a 
severe hypomyelination and premature death (Readhead et al., 1994). This mouse models 
prove that alterations in the Plp1 gene lead to an aberrant myelination, thereby confirming 
again the importance of PLP in myelin biogenesis. There are as well several 
leukodystrophies due to the mutation of the X-linked gene encoding PLP in humans. The 
PLP-deficiency is observed in spastic paraplegia type 2 (SPG2, OMIM no. 312920) patients. 
While Pelizaeus–Merzbacher disease (PMD, OMIM no. 312080) is most commonly caused 
by duplications of the PLP1 gene, but also by deletions, triplications and point mutations. 
Both are CNS dysmyelinating pathologies, but with a broad clinical spectrum: from the mild 
SPG2 forms to the severe connatal PMD (reviewed in Garbern, 2006; Woodward, 2008).  
 
 
2.2.2. The oligodendroglial and neuronal glycoprotein M6B 
The glycoprotein M6B, and ortholog to PLP, with 2 potential N-linked glycosylation sites (Yan 
et al., 1993), was lately proven to be actually a glycosylated protein (Fünfschilling U., pers. 
comm.). The mammalian Gpm6b gene has a complex transcription and splice scheme and 
encodes eight different protein isoforms, differentially expressed. The subcellular localization 




Abundant M6B expression has been detected in both neurons and OLs (Yan et al., 1993, 
1996; Werner et al., 2001) and its expression is throughout the brain and spinal cord (Yan et 
al., 1996). There are also faint expression levels of M6B mRNA in many non-neuronal 
tissues, including testis, liver, spleen, kidney, muscle, heart and lung (Werner et al., 2001; 
Isensse et al., 2008). During CNS development, M6B mRNA has first been detected in the 
ventricular zone; as early as at embryonic (E) day 10 (Yan et al., 1996), indicating its 
expression in proliferating and differentiating cells. 
 
M6B has been detected by immunoblotting in a myelin-enriched brain fraction (Klugmann et 
al., 1997), without presenting abundance differences between wild-type and PLPnull mice; 
and M6B represents approximately 1% of total CNS myelin proteins (citing Jahn et al., 2009, 
from Möbius et al., 2009). M6B is functionally redundant to PLP with respect to myelin 
biogenesis (Werner et al., pers. comm.).  
 
In primary cultures of hippocampal neurons the overexpression of M6B induces filopodia 
formation, similar to M6A (see below). Chronic restraint stress in mice leads to a decrease in 
M6B mRNA levels in the hippocampus (Fernández et al., 2010). 
 
Recently, it has been shown that M6B interacts with the serotonin transporter (SERT), a 
sodium- and chloride dependent transporter that mediates active re-uptake of the 
neurotransmitter serotonin at the synapses. Co-expression of SERT with M6B led to a 
reduced SERT expression at the cell surface and diminished the serotonin uptake in vitro 
(Fjorback et al., 2008). M6B may therefore regulate serotonin uptake by regulating the 
trafficking of the serotonin transporter.  
 
The human M6B gene (GPM6B) is located at Xp22.2 (Olinsky et al., 1996) and has been 
associated with a susceptibility locus for sickle cell anemia (OMIM no. 603903) (Sebastiani et 
al., 2008). GPM6B has also been considered a candidate to cause neurological diseases 
that have been mapped to the Xp22 region, but no GPM6B mutations were detected in 
analyses of patients with Rett syndrome (OMIM no. 312750) (Narayanan et al., 1998) or 
Xp22-linked recessive mental retardation (OMIM no. 309530) (Turner et al., 2003). It is also 
unlikely that mutations in GPM6B are involved in the Pelizaeus–Merzbacher-like disease 
(PMLD, OMIM no. 608804), a subgroup of human hypomyelination disorders (Henneke et 
al., 2004; Combes et al., 2006). PMLD is a leukodystrophy with diffuse hypomyelination. The 
patients have a clinical course very similar to PMD and represent about 20% of all cases with 
a clinical PMD phenotype, but lack PLP1 gene duplications or mutations (Henneke et al., 
2004). Nevertheless, it was recently found a decreased expression of the GPM6B gene in 
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male suicide completers in a population of French Canadians (Fiori et al., 2011). In female 
mammals most genes are silenced on one X chromosome as a result of the X-chromosome 
inactivation. However, some genes escape this and are then expressed in both, leading to 
potential sexual dimorphisms. The human GPM6B has been proven to escape this X-
inactivation (Carrel et al., 2005) and shows decreased expression in females (Isensse et al., 
2008).  
 
Together, it is known that M6B is important and partially functionally redundant to PLP in 
CNS compact myelin. Moreover, by its neuronal expression, it has been related mainly to 
filopodia formation in vitro and to the regulation of the SERT.  
 
 
2.2.3. The neuronal glycoprotein M6A 
M6A, also known as glycoprotein M6A (GPM6A), because of its N-glycosylation (Lagenauer 
et al., 1992; Baumrind et al., 1992) or edge membrane antigen (EMA) (Baumrind et al., 
1992), was cloned as the antigen of the monoclonal M6 antibody, and has 30 kDa (Yan et 
al., 1993). The human GPM6A gene is located at 4q34 (Olinsky et al., 1996) and there are 
two splice variants in rodents and humans: M6a-Ia and M6a-Ib, being M6a-Ib more 
predominantly expressed in the brain (Cooper et al., 2009). The two isoforms differ in their N-
terminal cytoplasmic domain (Werner et al., 2001). 
 
M6A is an abundant cell surface protein on postmitotic neurons in the CNS and is not 
present in OLs or glial precursors (Lagenauer et al., 1992; Baumrind et al., 1992). It is 
expressed already at E10 in postmitotic neurons of the developing neural tube and at E11 
M6A is detected throughout the brain (Baumrind et al., 1992) and spinal cord, where it is 
maintained throughout adult life (Lagenauer et al., 1992; Yan et al., 1996). M6A is also 
expressed in the retina of adult mice (Lagenauer et al., 1992). Immunohistochemistry reveals 
a wide expression in the CNS (Lagenauer et al., 1992; Baumrind et al., 1992). M6A is also 
expressed in cells of the epithelial layer of the choroid plexus and in renal proximal tubules, 
but not in PNS neurons (Lagenauer et al., 1992; Baumrind et al., 1992). The abundance of 
M6A augments strongly during neuronal differentiation, when the neurite outgrowth takes 
place in postmitotic neurons (Lund et al., 1986; Yan et al., 1996). During the maturation of 
the CNS the expression of M6A decreases, coinciding with myelination, in e.g. the pyramidal 
tract, corpus callosum, optic nerve and retina (Mi et al., 1998). However, it remains 
extensively in non-myelinated axons like cortical pyramidal neurons, cerebellar granule cells 
and glutamatergic presynaptic terminals (Lund et al., 1986; Cooper et al., 2008). 
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In the early 1990’s it was revealed in cultured cortical neurons (by immuno-fluorescence and 
freeze-etch immuno-electron microscopy) that although M6A is present on the plasma 
membrane of neuronal cell bodies and processes, it has an enriched and non-uniform 
distribution (Fig. 5) on lamellipodia and filopodia at the leading edges of the neuronal growth 






Figure 5. M6A is enriched at the leading edge of growth cones.  
Freeze-etch immuno-electron micrograph revealing M6A labelling on neuronal growth cones. There 
is an enriched M6A labelling at the leading edge of lamellipodia and along filopodia. Scale bar = 0.2 
µm (Taken from Baumrind et al., 1992). 
At that time it was also realized that upon acute addition of the monoclonal M6 antibody, 
cultured cerebellar neurons experienced a reduced neurite extension, without altering the 
motility of the filopodia or lamellipodia from the growth cones and without presenting a 
growth cone collapse (Lagenauer et al., 1992). This result suggested for the first time that 
M6A could be involved in neurite elongation. In vitro studies overexpressing M6A in primary 
hippocampal neurons revealed an increased number of neurites (Alfonso et al., 2005). An 
augment in neurite outgrowth has also been shown in M6A overexpressing mouse retinal 
progenitor cells (Zhao et al., 2008). Thereby, by in vitro experiments, M6A seems to be 
involved in neurite outgrowth.  
 
Regarding filopodia, in vitro studies overexpressing M6A in primary hippocampal neurons 
revealed an increased number of filopodia (Alfonso et al., 2005) and an increased motility of 
them (Brocco et al., 2010). The loss-of-function experiment (with small interference RNA) 
decreased the number of filopodia (Alfonso et al., 2005). The importance of the glycosylation 
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status was investigated by Fuchsova et al. (2009) by overexpressing M6A with mutations 
that abolish the two N-glycosylation sites of the extracellular domain (EC) EC2 in the 
neuroblastoma cell line N2a. This did not alter the induction of filopodia nor cell surface 
expression of M6A. Recently it was shown that the Src and MAPK kinases seem to be 
involved in the filopodia formation after M6A overexpression (Scorticati et al., 2011). 
Consequently, it appears that M6A, as well as M6B, is involved in filopodia formation in in 
vitro systems.  
 
The suppression of M6A mRNA in mouse and human embryonic stem (ES) cells inhibits their 
differentiation and proliferation (Michibata et al., 2008, 2009). While the overexpression of 
the human M6A in human ES cell lines enhanced their differentiation and proliferation. 
Additionally, this overexpression led to an increased neuronal migration, and vice versa in 
the suppression (Michibata et al., 2009). This points to a role of M6A in differentiation and 
neuronal migration of neurons derived form ES cells. On the other hand, overexpression of 
M6A in mouse retinal progenitor cells did not affect their differentiation and proliferation 
(Zhao et al., 2008). 
 
The association of M6A and lipid rafts has been assessed in cultured hippocampal neurons 
(Scorticati et al., 2011) and it has also been shown to be palmitoylated (Kang et al., 2008). 
The involvement of lipid rafts and palmitoylation in proteolipid biology has also been 
described above PLP (see 2.2.1.), and could provide a link on the molecular functioning of 
this protein family.  
 
Also in primary hippocampal neurons the suppression of M6A mRNA decreased the density 
of synaptophysin-positive presynaptic clusters (Alfonso et al., 2005). And it seems that in 
hippocampal neurons the EC2 plays an important role in synaptogenesis (Fuchsova et al. 
2009). M6A has been detected in the presynaptic membrane and synaptic vesicles by 
immuno-electron microscopy (Roussel et al., 1998) and in a synaptosomal rat brain fraction 
by mass-spectrometry (Takamori et al., 2006). M6A affects endocytosis at the mature 
presynapses and subcellular sorting of G-protein-coupled receptors such as the µ-opioid 
receptor (Wu et al., 2007; Liang et al., 2008). M6A associates with the µ-opioid receptor and 
enhances its endocytosis and sorting into the recycling pathway. M6A also interacts with 
other G protein-coupled receptors such as the δ–opioid receptor, the cannabinoid type 1 
receptor and the somatostatin receptor sst2A (Wu et al., 2007).  
 
M6A mRNA levels were found to be significantly reduced in the adult hippocampus in 
response to chronic psychosocial and restrain stress, an effect that is conserved across 
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species and that can be prevented by antidepressant treatment. It has been shown before 
that stress can lead to disorders like depression (Alfonso et al., 2004, 2006; Cooper et al., 
2009). These experiments indicate a role of M6A in neuronal plasticity. An association of the 
GPM6A gene with a subgroup of schizophrenia patients with high levels of depression was 
found (Boks et al., 2008). This supports that M6A is involved in alterations that take place in 
the hippocampus upon stress induction, like in many psychiatric disorders as depression or 
schizophrenia.  
 
Although M6A and M6B seem to play significant roles in neuronal development and function, 
initial evaluation of the single-null mutant mice (Gpm6anull and Gpm6bnull) did not reveal any 
major differences in the CNS histology in mature animals. Also in Gpm6anull*Gpm6bnull mice, 
no abnormalities were found at the adult histological level. However, Gpm6anull*Gpm6bnull 
mice do show an increased mortality after weaning (of approximately 20%) and they have a 
reduced motor performance at the rotarod test at one month of age (Burzynska A., 
Fünfschilling U., Werner H., pers. comm.). This results show that there are some in vivo 
abnormalities when the neuronal M6 proteins lack chronically, but the involvement of the M6 
proteins in the CNS biology has to be further examined.  
 
 
2.3. Tetraspanins  
The tetraspanins also termed transmembrane four superfamily (TM4SF) members are small 
(20-30 kDa), membrane proteins that are expressed ubiquitously and are evolutionary highly 
conserved (Hemler, 2008).  
 
Tetraspanins comprise a large family of cell-surface proteins expressed in protozoan 
amoebae, some sponges, fungi, plants and metazoans. They seem to have an evolutionary 
role in the transition form uni- to multicellularity (Huang et al., 2005; Hemler, 2005). There are 
33 tetraspanins in humans, 35 in D. melanogaster and 20 in Caenorhabditis elegans (Garcia-
España et al., 2008). The Drosophila tetraspanin late bloomer (lbl) is expressed during 
development at the growth cones and terminal arbores of motor axons. It has been shown 
that it acts as a cell adhesion protein important for synapse formation at the neuromuscular 
junction (Kopczynski et al., 1996) and that other tetraspanins expressed on motor neurons 
have a redundant function and can compensate when Late Bloomer is absent (Fradkin et al., 
2002).  
 
Structurally, tetraspanins have four transmembrane domains with polar residues close to 
these and four to six conserved Cys residues in their EC2 (Stipp et al., 2003, Levy & 
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Shoham, 2005a) that lead to protein structure stabilizing disulfide bridges (Levy & Shoham, 
2005b) This structure is similar to the structure of proteolipids, where the two disulfide 
bridges have been proven e.g. to be essential for the proper PLP function (Dhaunchak & 
Nave, 2007). The polar charges of the transmembrane domains mediate hydrophobic 
tetraspanin-tetraspanin interactions (Kovalenko et al., 2005). Apart form these characteristics 
they possess a small EC1, a much larger EC2 with consensus N-glycosilation sites (Hemler, 
2005) and short N- and C-terminal termini (Stipp et al., 2003; Kovalenko et al., 2005). The 
EC2 is compartmentalized into two regions: the constant region (ABE α-helixes) and the 
variable region (CD α-helixes), the latter being essential for protein-protein interactions 
(Seigneuret et al., 2001; Stipp et al., 2003, reviewed in Hemler, 2005). The cytoplasmic 
domain is less conserved and there are sorting signals in some tetraspanins, which probably 
links them to cytoskeletal and signalling molecules. There are several highly conserved 
membrane-proximal palmitoylation sites that are required for the initial tetraspanin-
tetraspanin complex formation (Stipp et al., 2003; Levy & Shoham, 2005b). The S-
palmitoylation is reversible, increases the hydrophobicity of the proteins and was shown to 
influence the subcellular distribution and lateral associations of tetraspanins and their partner 
proteins (Levy & Shoham, 2005a). So, e.g., the tetraspanins tetraspanin2 (TSPAN2), CD9 
(cluster of differentiation 9) and CD81 have six possible palmitoylated Cys (Stipp et al., 
2003). 
 
Tetraspanins have been associated with a large number of biological processes such as the 
regulation of cell motility, invasion and fusion, proliferation and differentiation as well as 
signalling and protein trafficking (Hemler, 2008). They accomplish these functions e.g. during 
infectious diseases and fertilization and in the immune and nervous system (Hemler, 2008). 
The most distinct characteristic of the tetraspanins is the ability to organize multimolecular 
membrane complexes by establishing dynamic lateral associations with each other and 
multiple partner proteins and assembling them into the so called “tetraspanin web” 
(Rubinstein et al., 1996) or “tetraspanin-enriched microdomains” (TEMs), which are cell-type 
specific, regarding their exact molecular composition (Hemler, 2005). Unusually, they can 
also act as cell-surface receptors, like e.g. the tetraspanin CD81 that has been identified as 
the receptor for the hepatitis C virus envelope protein E2 (reviewed in Levy & Shoham, 
2005a). 
 
The levels of TEM interactions can be subdivided into different classes as a simplified 
approach to its complexity (this has been excellently reviewed by Hemler, 2005). The first 
level would consider the robust and direct homo and hetero protein-protein interactions that 
can take place extra- as well as intracellularly, as e.g. the CD9-CD9 interaction. These are 
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specific and soluble interactions (Hemler, 2005). The second level describes the indirect 
protein interactions in which several direct homophilic and heterophilic primary complexes 
assemble into a network of secondary interactions (Tarrant et al., 2003). Potential 
tetraspanin partners are e.g. integrins and members of the immunoglobulin superfamily. 
Through this mechanism, different partner proteins get recruited through tetraspanins into 
functionally important complexes. Palmitoylation seems to be very important for the 
maintenance of this type of interactions (Levy & Shoham, 2005a). It is specific for 
tetraspanins that they can take part in different protein-protein interaction according to the 
cell type (Levy & Shoham, 2005b). The class three interactions account for the formation of 
insoluble complexes, when milder non-ionic detergents are used and tetraspanin complexes 
begin to show partial insolubility. These last two types of interactions are potentially very 
relevant due to their dynamic status (Tarrant et al., 2003). Functionally, these interactions 
cluster in TEMs, enabling lateral dynamic organization in the membrane and the connection 
with intracellular signalling and cytoskeletal structures (Levy & Shoham, 2005a; Yáñez-Mó et 
al., 2009). Thereby the robust level one interaction represents specific functions for concrete 
tetraspanins, while level two and three interactions are weaker and embody the general 
function of tetraspanin in TEMs: acting as “molecular facilitators” (Maecker et al., 1997) that 
enable the lateral dynamical organization in the membrane and the cross-talk with 
intracellular signalling and cytoskeletal structures (Hemler, 2001). This complex and multiple 
levels of interaction explain how tetraspanins can be involved in this plethora of cell 
functions. 
 
Tetraspanins can also associate with three different types of lipids: cholesterol (Charrin et al., 
2003), gangliosides and palmitate (Levy & Shoham, 2005a, Hemler, 2005). Tetraspanin 
complexes are resistant to solubilisation by milder detergents, thereby they have been 
proposed to form membrane microdomains distinct form lipid rafts (Hemler, 2005; Israels & 
McMillan-Ward, 2007). In contrary to lipid rafts, TEMs are not disrupted at 37°C, they are 
resistant to cholesterol depletion, mostly soluble in non-ionic detergents and they do not 
comprehend GPI-linked proteins or caveolin (Hemler, 2005).  
 
 
2.3.1. Tetraspanins in myelin 
The tetraspanin proteins that are known today to be in CNS myelin are: TSPAN2 (Birling et 
al., 1999), CD9 (Tole & Patterson, 1993), CD81 (Sullivan & Geisert, 1998), CD82 (Jahn et 
al., 2009), OAP-1 (Bronstein et al., 2004), CD63 and CD151 (Baer et al., 2009).  
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CD63 and CD151 have, until now, only appeared in a CNS myelin blue native experiment 
(Baer et al., 2009), but there is no further literature explaining their role in OLs or myelin. 
CD63 was the first characterized tetraspanin and is abundant in late endosomes and 
lysosomes. As a tetraspanin it interacts with many proteins like integrins, kinases and also 
other tetraspanins like CD9, CD81, CD82 and CD151 (reviewed in Pols & Klumperman, 
2008). CD151 is present in most epithelial and fibroblastic cells and has been proven to act 
in an integrin-dependent manner on cell morphology, adhesion and motility (reviewed in 
Hemler, 2005). Until now, CD63 and CD151 have been vastly examined outside the nervous 
system and further studies involving neural cells will demonstrate the function of these 
proteins in the CNS.  
 
The myelin tetraspanins CD9, CD81 and CD82 have been all shown to directly interact with 
cholesterol (Charrin et al., 2003), what already gives a hint of their potential function and 
importance in myelination.  
 
Phylogenetic analysis has shown that CD9, CD81 and TSPAN2 form a cluster, thereby being 
all very closely related orthologs (Garcia-España et al., 2008). All the three members of this 
subgroup of tetraspanins contain two disulfide bridges in their EC2 (Charrin et al., 2009). By 
immunoprecipitation it was found out that CD9 interacts with β1integrin, CD81 and TSPAN2 
(Terada et al., 2002). And this stands again for a similar and partially simultaneous role of 
CD9, CD81 and TSPAN2 in the OL biology.  
 
During development CD9 (TSPAN29) is expressed in motorneurons (Tole & Patterson, 1993) 
and glia precursor cells (Deissler et al., 1996), but in the adult its expression is mainly in CNS 
and PNS glia (Tole & Patterson, 1993), and it seems that it is more abundant in the PNS 
than in the CNS (Ishibashi et al., 2004). CD9 is present in human CNS and PNS myelin 
(Nakamura et al., 1996) and in premyelinating OLs and mature myelinating OLs (Terada et 
al., 2002). In the course of CNS myelination, CD9 appears when myelination is very 
advanced, after PLP (Kagawa et al., 1997), and ultrastructural analysis have confirmed that 
in the CNS CD9 is detected at the outermost membrane of compact myelin (Nakamura et al., 
1996), in the PNS in non-compact regions (Tole & Patterson, 1993) and in both it is found as 
a paranodal protein (Ishibashi et al., 2004). By studying the CD9null mutant mice it was 
revealed that CD9 does have a role in organizing the paranode, but the CNS myelin showed 
no aberrant compaction and there was only a restricted hypermyelination in the PNS 
(Ishibashi et al., 2004). This demonstrate a different role and implication of CD9 in CNS Vs 
PNS myelination and indicates the possible function of CD9 being a tetraspanin in organizing 
the interaction with and of different proteins.  
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CD81 (TSPAN28) is expressed in the CNS by the major glia cell types: OLs, astrocytes and 
microglia (Geisert et al., 2002). CD81 has a very broad tissue expression (peripheral nerve, 
muscle, liver, kidney, skin, testicle, etc.), but it is particularly abundant in the brain. Its 
expression is upregulated during early postnatal development, at the time of glial 
development and maturation, and at P14 the levels approach those of the adult (Sullivan & 
Geisert, 1998). CD81null mutants encompass brain enlargement and augmentation in the 
number of astrocytes and microglia, while the number of OLs is unaltered. The general 
myelination pattern is similar to wild-type mice (Geisert et al., 2002).  
 
CD82 (TSPAN27) has been recently revealed to play a role in CNS myelination. Apart form 
the high expression of CD82 in mature OLs in vitro and in vivo, CD82 is an important factor 
in promoting the differentiation from pre-myelinating OLs to myelinating OLs (Mela & 
Goodman, 2009). Further studies will probably reveal that this function of CD82 relies on 
assembling protein networks, as most tetraspanins do.  
 
OAP-1 (OSP/claudin-11–associated protein 1 or TSPAN3) is an interaction partner of the 
tetraspan oligodendrocyte-specific protein (OSP)/ claudin-11, a main component of CNS 
myelin that forms tight junctions within myelin sheaths (Tiwari-Woodruff et al., 2001). It is N-
glycosilated and broadly expressed, e.g. spinal cord, brain, testes, skeletal muscle and heart, 
in neurons, astrocytes and OLs (Tiwari-Woodruff et al., 2001; Bronstein et al., 2004), and in 
all stages of OL development (Bronstein et al., 2004). In the CNS, its expression increases 
during development and OAP-1 is found in the germinal zones and is still broadly expressed 
in the adult, also in myelin (Bronstein et al., 2004). In vitro studies demonstrated a role of 
OAP-1 in OL proliferation and, through the complex of OAP-1/OSP/β1integrin, also in OL 
migration (Tiwari-Woodruff et al., 2001). The interaction of OAP-1 with OSP/claudin-11 and 
integrins points to a possible role in the fine-tuning of the interaction of different cells, with an 
involvement in migration and proliferation.  
 
 
2.3.2. Tetraspanin2: A role in myelination? 
The murine TSPAN2 is a nervous system specific protein that is present in OLs and CNS 
myelin. It has 24 kDa and one potential N-glycosilation site at EC2 (Birling et al., 1999). The 
mRNA expression commences just when myelination starts (at P3, before PLP) mainly in the 
hindbrain and increases caudorostrally until it peaks at P22, coinciding with the major 
myelination phase, and is than reduced to the adult level. TSPAN2 is found also in some 
neuronal subpopulation of cerebellar nuclei (Birling et al., 1999). The mRNA is found in brain 
tissue as well as in sciatic nerve (Birling et al., 1999), although the protein has not been 
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detected so far in the PNS (Werner H., pers. comm.). The TSPAN2 protein is found in the 








Figure 6. Localization of TSPAN2 in brain sections. 
Confocal microscopy performed on sagital sections from P31 rat brain stained against TSPAN2. The 
expression is found in compact myelin as it colocalizes widely with MBP (marker for compact myelin). 
Depicted are cross-sections (arrows) and longitudinal sections (arrowheads) of individual axons 
surrounded by myelin. Scale bar = 5 µm (Taken from Birling et al., 1999). 
Different transcriptomic analyses have demonstrated an upregulation of TSPAN2 during OL 
differentiation (Nielsen et al., 2006; Dugas et al., 2006). And there has been shown an 
upregulation of cortical mRNA levels of TSPAN2 after the application of a traditional Chinese 
medicinal treatment (Huang-Lian-Jie-Du decoction) that improves learning and memory 
function in the senescence-accelerated mouse/prone 8 mice, a model for age-related 
learning and memory deficits (Yue et al., 2008). Additionally, OLs cultured under oxygen 
glucose deprivation conditions have a decrease in TSPAN2 mRNA. While OLs cultured 
under these conditions and treated with human umbilical cord blood cells that have a 
protective effect on white matter tracts, show an increase in their TSPAN2 mRNA expression 
levels (Rowe et al., 2010). 
 
Thereby, until now it is known that TSPAN2 is present during OL differentiation and in CNS 
compact myelin. But how TSPAN2 could act on OL differentiation as well as myelination or 
myelin maintenance is completely unidentified. Because of being a member of the 
tetraspanin family it is straightforward to speculate about an involvement in signalling and in 
coordinating and arranging interacting proteins in the OL plasma membranes and myelin 
sheaths.  
 
A surprising discovery was the drastic increase of the TSPAN2 levels in a CNS myelin-
enriched fraction of PLPnull mutant mice (Werner H., pers. comm.). As PLP and TSPAN2 are 
both structurally similar tetraspan proteins and expressed in OLs in a similar spatiotemporal 
pattern, this leads to the hypothesis that TSPAN2 could compensate for PLP in its absence.  
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2.4. Aim of the study 
Neuronal development involves the interplay of a large number of cell surface proteins. Two 
members of the M6-proteolipid protein family of tetraspan-transmembrane proteins are 
among the most abundant cell surface proteins in neurons, but their physiological role has 
remained largely obscure despite over 25 years of analysis. The majority of studies relied on 
acute reduction or augmentation of their abundance levels in vitro, and knowledge on their 
cellular function in vivo is entirely lacking. To achieve a better understanding of the function 
of M6 proteolipids (termed M6A, official gene name Gpm6a, and M6B, official gene name 
Gpm6b) during neuronal development I will analyse available GPM6Anull and GPM6Bnull 
mutant mice. Since both proteins are closely related orthologs, a partially redundant function 
has to be considered, and therefore GPM6Anull*GPM6Bnull double null mutant mice will be 
included. I will utilize an ex vivo cell culture system of primary cortical neurons in which both 
proteins are highly abundant. The study will involve life cell microscopy, 
immunocytochemistry, confocal analysis, as well as functional assays. Thereby I want to 
assess the detailed subcellular localization in neurons, as well as their functional involvement 
in neuronal development. Furthermore, I aim to investigate the consequences of the chronic 
lack of M6 proteins in long-projecting neurons at an early postnatal stage in vivo. 
 
A structurally related superfamily of tetraspan transmembrane proteins, the tetraspanins, has 
been related to various features of cell biology, including myelination of axons by the cellular 
processes of oligodendrocytes in the CNS. Tetraspanin-2 (TSPAN2) is particularly abundant 
at the onset of myelination and a constituent of mature compact CNS myelin, in which its 
abundance is very strongly increased in mutant mice that lack the most abundant myelin 
protein, proteolipid protein (PLP). I hypothesized that TSPAN2 can partially compensate for 
the absence of PLP in myelination, which would also explain that the abnormalities observed 
in PLPnull mutant mice are minor. To this aim I will generate TSPAN2null mutant mice by 
inactivating the Tspan2 gene using homologous recombination in embryonic stem cells. I will 
also generate TSPAN2null*PLPnull double null mutant with the aim to test for a possible 
cumulative effect of the lack of both tetraspan proteins in CNS myelin. The myelin protein 
composition will be characterized using biochemical methods.  
 
The aim of this thesis is to assess the role of the neuronal proteolipids M6A and M6B, as well 
as of the oligodendroglial proteolipid protein PLP and TSPAN2 in the growth of cellular 





3. Materials and Methods 
 
 
3.1. Materials  
 
 
3.1.1. Kits, chemicals and protocol source  
All chemicals used were purchased from the Sigma-Aldrich and Merck unless stated 
otherwise and all molecular biology kits were purchased from Qiagen, Macherey-Nagel, 
Promega or Sigma-Aldrich, while cell culture and general laboratory material were purchased 
from Falcon, Nunc and Eppendorf.  
 
 
3.1.2. Molecular biology buffers  
DNA-sample buffer (6x)  
20 % glycerol in TAE buffer  
0.025 % bromophenol blue  
 
dNTP-stock solutions (100 mM)  
25 mM of each dATP, dCTP, dGTP, dTTP (Boehringer, Mannheim)  
 
Ethidiumbromide  
1 - 1.5 μg/ml for agarose gels in 1x TAE  
 
Modified Gitschier buffer (MGB, 10x)  
6.7 ml 1 M Tris-HCl (pH 8.8)  
1.66 ml 1 M (NH4)2SO4 
650 μl 1 M MgCl2 
add dH2O up to 10ml  
 
MGB buffer (1x, working solution)  
1 ml 10x MGB  
100 μl β-mercaptoethanol  
500 μl 10 % Triton X-100  
8.4 ml dH2O  
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TAE (50x, 1000ml)  
2 M Tris-acetate, pH 8.0  
50 mM EDTA  
57.1 ml glacial acetic acid  
add dH2O up to 1000ml  
 
TE (1x)  
10 mM Tris-HCl, pH 8.0  
1 mM EDTA 
 
 
3.1.3. Protein biochemistry buffers  
10x Phosphate buffered saline (PBS) 
1.7 M NaCl 
34 mM KCl 
40 mM Na2HPO4 x 2H2O 
18 mM K2HPO4 
Adjust pH 7.2 with 1N NaOH. 
 
Modified RIPA buffer (protein lysis buffer) 
50 mM Tris-HCl, pH 7.4 
150 mM NaCl 
1 mM EDTA 
0.1 % SDS 
1.0 % sodium deoxycholate 
1.0 % TritonX-100 
 
Solutions for CNS-myelin enriched fraction 
0.32 M sucrose  
0.85 M sucrose (filtered sterile) 
 




3.1.4. SDS-PAGE and Immunoblotting 
Separating SDS gel (for 4 gels, 12 %, 1.5 mm thickness)  
13 ml dH2O  
15 ml 30 % Acrylamide (BioRad, 29.1)  
9.4 ml 1.5 M Tris-HCl (pH 8.8)  
370 μl 10 % SDS  
125 μl 10 % APS (Ammonium persulfate)  
30 μl TEMED (BioRad)  
 
Stacking SDS gel (4 gels)  
6.1 ml dH2O  
1.3 ml 30 % Acrylamide (BioRad, 29.1)  
2.5 ml 0.5 M Tris-HCl (pH 6.8)  
100 μl 10 % SDS  
50 μl 10 % APS (Ammonium persulfate)  
10 μl TEMED  
SDS running buffer (Laemmli buffer, 1x)  
25 mM Tris-HCl  
192 mM Glycine  
1 % (w/v) SDS  
 
SDS sample buffer (6x)  
7 ml 0.5M Tris-HCl buffer (pH 6.8)  
3 ml Glycerol (30 % final concentration)  
1 g SDS  
1.2 ml 1 % Bromophenol blue  
0.2 - 2 % β-Mercaptoethanol (add fresh)  
 
Transfer buffer (1x)  
48 mM Tris base  
39 mM Glycine  
10-20 % Methanol  
 
Blocking Buffer  




Western blot stripping buffer  
0.2 M Glycine-HCl, pH 2.5  
0.1 % Tween-20  
 
Tris buffered saline (TBS, 20x)  
1 M Tris base  
3 M NaCl  
Adjust pH 7.4 (with HCl)  
 
TBS with Tween-20 (TBST, 1x)  
50 mM Tris-HCl (pH 7.4 - 7.6)  
150 mM NaCl  
0.05 % - 0.15 % Tween-20  
 
Enhanced Chemiluminescence (ECL) Western-blot detection kit 
Western Lightning™ Plus-ECL, Enhanced luminol reagent plus (Perkin Elmer Life Sciences, 
Inc.). 
ECL-Hyperfilms (Amersham Biosciences) 
PVDF membrane -Hybond P pore size 0.45 μm (Amersham) 
 
 
3.1.5. DNA and Protein markers  
GeneRuler 1 kb DNA ladder (Fermentas)  
GeneRuler 100 bp DNA ladder (Fermentas)  
Prestained Page Ruler Plus (Fermentas) 
 
 
3.1.6. Immunocytochemistry buffers  
4 % Paraformaldehyde in PBS/TBS 
100 ml 0.2 M NaH2PO4 (Sodiumdihydrogenphosphate)  
400 ml 0.2 M Na2HPO4 (di-Sodiumhydrogenphosphate)  
108 ml 37 % Formalin  
392 ml dH2O  




Blocking Buffer  
2 % BSA in PBS 
 
Mounting Agent  
Aqua polymount (Polysciences)  
 
 
3.1.7. Immunohistochemistry buffers  
Phosphate buffer (stock solution)  
0.2 M NaH2PO4  
0.2 M Na2HPO4  
 
Phosphate buffer (working solution, pH 7.4)  
20 ml 0.2 M NaH2PO4  
80 ml 0.2 M Na2HPO4  
100 ml dH2O  
 
Bovine Serum Albumin (PBS/BSA)  
20 ml 0.2 M NaH2PO4  
80 ml 0.2 M Na2HPO4  
1.8 g NaCl  
1 g BSA  
100 ml dH2O  
 
Citrate Buffer (stock solution, stored 4°C) 
0.1 M Citric acid (C6H8O7*H2O)  
0.1 M Sodium citrate (C6H5O7Na3*2H2O)  
 
Citrate Buffer (working solution, 0.01 M, pH 6.0, prepared freshly)  
9 ml 0.1 M Citric acid (C6H8O7*H2O)  
41 ml 0.1 M Sodium citrate (C6H5O7Na3*2H2O)  
450 ml dH2O  
 
Tris Buffer (stock solution, stored 4°C)  
0.5 M Tris base  
Adjust pH 7.6 with HCl  
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Tris Buffer (working solution, prepared freshly)  
100 ml 0.5M Tris base (pH 7.6)  
9 g NaCl  
Add up to 1000 ml with dH2O  
 
Blocking buffer (2 % milk powder in Tris Buffer)  
20 g of non-fat milk powder  
Add up to 1000 ml with Tris buffer  
 
 
3.1.8. Histological stains and reagents  
Mayer’s Haematoxylin solution  
1 g Haematoxylin (Merck) was dissolved in 1000 ml dH2O and 0.2 g sodium iodate and 50 g 
potassium aluminium sulphate (K2Al2(SO4)4*24H2O) was added under constant shaking. 
Finally, 50 g chloralhydrate and 1 g citric acid were added and the solution was filtered 
before use.  
 
Eosin solution  
Stock solution (10x)  
10 g of Eosin were dissolved in 100 ml of dH2O and left to mature.  
 
Working solution  
2.5 ml stock solution  
250 ml dH2O  
12 drops glacial acetic  
 
Scott’s solution  
2 g KHCO3 (potassiumhydrogencarbonate)  
20 g MgSO4 (magnesium sulphate)  
Add up to 1000 ml with dH2O  
 
HCl- Alcohol  
1.25 ml HCl  
350 ml Ethanol  




3.1.9. Oligonucleotides  
Oligonucleotides were synthesized in the “DNA core Facility” of the Max-Planck-Institute of 
Experimental Medicine.  
 
Genotyping primers  
Nested external PCR:  
Forward: 5'-CTTCATCTTTGTCTCCAGTT -3' 
Reverse: 5'-GCAATCCATCTTGTTCAATGGC -3' 
 
Nested internal PCR: 
Forward: 5'-CTCCTTAATCTTCACAACTCTT -3' 
Reverse: 5'-CCATCTTGTTCAATGGCCGATC -3' 
Amplification product: 2.1 kn in control vector and 1.6 kb in homologous recombined ES cells 
 
TSPAN2null: 
Forward: 5'-CCATAGACACGCAGGATAACTTCAACCA -3' 
Reverse: 5'-GGCTTTTTGCTTCCTCTTGA -3' 
Reverse: 5'-GTTGGGAGGGGCGTGACCTGT -3' 
Amplification product: 196 bp for mutant and 286 bp for wild-type 
 
PLPnull: 
Forward: 5‘-TTG GCG GCG AAT GGG CTG AC-3‘ 
Forward: 5‘-GGA GAG GAG GAG GGA AAC GAG-3‘ 
Reverse: 5‘-TCT GTT TTG CGG CTG ACT TTG-3‘ 












Amplification product: 700 bp for mutant and 400 bp for wild-type 
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3.1.10. Antibodies and recombinant proteins 
Primary antibodies for immunocytochemistry: 
M6A  Rat   1:1500  MBLInternational Corporation.  
M6B (#8547)  Rabbit   1:500  (Werner et al., 2001) 
Tuj1  Mouse  1:500  Sigma 
Primary antibodies for immunoblot: 
A431 (PLP)   Rabbit  1:5000  (Jung et al., 1996) 
Actin  Mouse  1:500   Sigma 
CD9   Rat  1:250  BD Pharmingen 
CD63   Mouse  1:1000  Calbiochem 
CD81  Hamster 1:2000  BD Pharmingen 
CD82  Rabbit  1:500  Novus Biologicals 
CNP  Mouse  1:1000  Sigma 
Ephexin-1 Rabbit  1:1000  ECM Biosciences 
Fyn   Rabbit  1:500  Santa Cruz 
MBP   Mouse  1:500  Chemicon 
RhoA   Rabbit  1:1000  Cell signalling 
TSPAN2  Rabbit  1:600  (Biriling et al., 1999) 
Tubulin  Mouse  1:5000  Sigma 
 
Primary antibodies for immunohistochemistry: 
TSPAN2  Rabbit  1:1000   (Biriling et al., 1999) 
 
Secondary antibodies:  
HRP-anti mouse  1:5000  Dianova 
HRP-anti rabbit  1:5000  Dianova 
HRP-anti rat   1:2000  Dianova 
HRP-anti hamster   1:2000  abcam 
Cy2-anti rat    1:100  Dianova  
Cy3-anti mouse   1:1000  Dianova 
Cy5-anti rat   1:1000  Dianova 
 
Others : 
Rhodamine-Phalloidin  1:100  Invitrogen  
 
Recombinant proteins for the ephrinA5 “growth cone collapse assay”: 
Recombinant human ephrin-A5/Fc Chimera, CF, R&D systems 
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Recombinant human IgG1 Fc, R&D systems 
Anti-human IgG; Fc specific, Sigma 
 
 
3.1.11. Enzymes  
CIP (alkaline phosphatase)   Roche 
DNase     Qiagen 
GoTaq polymerase    Promega 
Pfu high fidelity DNA polymerase  Stratagene 
Proteinase K     Roth 
REDTaqDNA polymerase   Sigma-Aldrich 
Restriction enzymes    New England Biolabs 
T4 DNA ligase    Promega 
 
 
3.1.12. Bacteria and bacterial culture media 
Bacterial strains 
Escherichia coli XL1-Blue (Stratagene) 
 
LB medium (Luria and Bertani medium) 
1 % Bacto-Pepton 
0.5 % Yeast extract 
1 % NaCl 
pH7.5, adjusted with 10 N NaOH and autoclaved. 
Selective LB media was supplemented with following antibiotics: 
100 μg/ml Ampicillin 
50 μg/ml Kanamycin 
 
LB-Agar plates 
1 % Bacto-Pepton 
0.5 % Yeast extract 
1 % NaCl 
1.2% Bacto-agar 
pH7.5, adjusted, autoclaved and left to cool to 55°C  
desired antibiotics are added. 
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3.1.13. Cell culture media  
Components were purchased from GIBCO or Lonza.  
 
Neurobasal complete medium for cortical neurons 
100ml Neurobasal medium  
2ml B27 Supplement  
1ml Glutamax 10x  
1ml 1 % Penicillin/Streptomycin  
 
Hank’s Balanced Salt Solution (HBSS+) for preparation of brains  
500 ml HBSS  
7.5 ml 10 % MgSO4  
 
DNAse in HBSS (0.05 %)  
Dilute 100 mg in 200 ml HBSS, Freeze aliquots at -20°C 
 
Papain in PBS (20U/ml) 
 
Cholesterol (C3045, Sigma) 
diluted in ethanol  
 
ES-cell medium (600 ml) 
474 ml DMEM (4,5 g Glucose/l)  
6 ml aminoacids (100x)  
6 ml Sodiumpyruvat (100x)  
6 ml Penicillin/Streptomycin (100x) 
6 ml L-Glutamin (100x) 
6 ml β-mercaptoethanol (10 mM in PBS) 
6 ml LIF (107 U/ml)  
90 ml FCS  
 
Gelatine (500 ml) 
0.5 mg gelatine  




3.1.14. Mouse lines  
PLPnull mice (Klugmann et al., 1997)  
GPM6Anull mice (generated by Klugmann M.) 






3.2.1. Molecular biolological methods 
 
 
3.2.1.1. Transformation of chemical competent E. coli (XL-1 blue) 
100 µl of chemical competent Escherichia coli (E.coli) were thawed on ice, transferred into 14 
ml Falcon tubes, 50 ng of plasmid DNA was added and incubated for 30 min on ice. A heat 
shock was performed at 42°C during 40 sec and than the bacteria were put back on ice for 2 
min. Afterwards, 800 µl of LB-medium without antibiotic was added to the tube and the 
bacteria were incubated under rotation at 37°C for 30 min. 50 to 200 µl of this culture were 
plated on LB plates with the appropriate antibiotic, and incubated ON at 37°C.  
 
 
3.2.1.2. DNA purification at small scale (“mini prep”) 
For preparing small amounts of plasmid DNA, the “QIAprep 8 Miniprep kit” (Qiagen) or 
“NucleoSpin Plasmid QuickPure kit” (Macherey-Nagel) were employed. The protocol is in 
accordance with the modified “alkaline lysis” protocol (Birnboim & Doly, 1979), in which the 
DNA binds to an anion-exchange resin and is subsequently washed and eluted. This occurs 
under specific pH levels and at low-salt conditions. Bacteria inoculated with a single 
transformed colony were grown ON at 37°C with gentle shacking in 3 ml LB medium with the 
appropriate antibiotic. 2 ml of these cultures were transferred into 2 ml microfuge tubes and 
centrifuged at 5000 rpm for 5 min, so that the bacteria were pelleted. The DNA of these 
bacteria was isolated according to the manufacturer’s protocol, and in the last step the DNA 




3.2.1.3. DNA purification at large scale (“maxi preps”) 
For preparing large amounts of plasmid DNA, the “NucleoBond PC500 EF Maxi kit” 
(Macherey-Nagel) was used, which is based as well as the “mini preps” (3.2.1.2.) on the 
“alkaline lysis” protocol (Birnboim & Doly, 1979). The RNA and low-molecular weight 
contaminations were removed with medium salt washes. The plasmid DNA is as in the “mini 
prep” eluted from an anion-exchange resin column, than precipitated with isopropanol and 
washed several times to remove remaining salts from the elution buffer. For this procedure, 2 
ml of plasmid DNA grown ON in 3 ml LB-medium with the appropriate antibiotic were 
inoculated in 250 ml of LB-medium with again the appropriate antibiotic and grown ON at 
37°C with gentle shacking. Bacteria were pelleted by centrifugation at 6000g for 30 min at 
4°C (SLA-1500 rotor). The “maxi prep” protocol was applied and the DNA was finally 
resuspended in 250 µl of endotoxin free ddH2O.  
 
 
3.2.1.4. Murine genomic DNA preparation 
Murine genomic DNA was prepared for genotyping, out of 5 mm large tail biopsies. Each tail 
was carefully placed into microfuge tubes with 200 µl lysis buffer (180 µl of 1xMGB, 20 µl 
proteinase K (10 mg/ml)) and incubated at 55°C ON with strong shaking.  The proteinase K 
of the genomic DNA lysates was heat-inactivated (95°C, 15 min), and then the lysates were 
centrifuged at 5000 rpm for 10 min to pellet the non-lysed debris. The supernatant was used 
for the genotyping PCRs. 
 
 
3.2.1.5. DNA restriction digest 
The DNA restriction digest is performed with restriction endonucleases, which recognize 
specific dsDNA sequences and cut the DNA at those sites, leaving sticky or blunt ends. The 
resulting dsDNA with 5’ and 3’ sticky ends can be further ligated to other digested dsDNA 
fragments, what gives them their relevance as an essential tool in molecular biology. In 
general, in an analytical digest, in a 20 µl digestion reaction with approximately 500 ng of 
DNA, 1 to 10 units of restriction enzyme were added and incubated at 37°C for 1 hour. The 





3.2.1.6. Digested DNA dephosphorylation 
By employing the calf intestinal phosphatase (CIP), 5’ phosphoryl groups were removed from 
digested DNA, to avoid their religation. 1 to 2 units of CIP were added to the digested DNA 
(with CIP buffer and the necessary ddH2O for a 1x concentration) and incubated at 37°C for 
30 min. The CIP is removed by DNA agarose gel extraction.  
 
 
3.2.1.7. DNA ligation  
The ligation of DNA fragments was performed in 10 µl reactions by mixing 25 to 50 ng of 
vector DNA, insert DNA in a 1:3 ratio, 0.5 µl of T4-ligase and 1 µl of 10x ligation buffer 
(Promega). It was incubated at RT for 1 hour, and the resulting product could be used 
directly for transformation.  
 
 
3.2.1.8. DNA gel-electrophoresis 
DNA gel electrophoresis was performed in order to separate DNA fragments, from 200 bp to 
6 kb, with gels containing 0.8 % to 2 % agarose concentration. The proper amount of 
agarose was dissolved in 1xTAE buffer and heated in a microwave. Once it had solved and 
cooled down ethidiumbromide was added (1 μg/ml) and the agarose was poured into 
custom-made gel trays and combs were placed in them to allow forming wells in the gel. 
Once the gel was solidified, it was transferred into a gel loading chamber and the DNA 
samples as well as standard DNA markers (100 bp or 1 kb ladder) (all containing sample 
buffer) were loaded. Gels were run under constant current (approximately 10 V/cm length) 
until the appropriate DNA band separation. For documentation, snapshots of UV-trans-
illuminated gels were taken. 
 
 
3.2.1.9. DNA extraction from agarose gels 
DNA fragments were excised under UV light from agarose gels according to the 
manufacturer’s protocols, and the “QIAquick Gel Extraction kit" (Qiagen) or “NucleoSpin 
Extract II kit” (Macherey-Nagel) were used. They are based on the DNA capacity to bind to 
silica-membranes under high-salt conditions at pH 7.5. At the last step, DNA was eluted in 25 
µl of ddH2O. 
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3.2.1.10. Determination of DNA concentrations 
The DNA concentrations were determined spectrophotometerically, according to the 
Lambert-Beer law, as a substance in solution is proportional to its absorption. The DNA was 
diluted 1:100 with water and the solution was pipetted into a cuvette and analysed in a UV 
spectrophotometer (Biophotometer, Eppendorf). The concentration was determined by 
measuring the absorbance at 260 nm, 280 nm and 320 nm. A ratio of A260/A280 between 
1.8 and 2 implies sufficient DNA purity.  
 
 
3.2.1.11. DNA sequencing 
16 µl of DNA samples (100 ng/µl in ddH2O) were sequenced at the “DNA core Facility” of the 
Max-Planck-Institute of Experimental Medicine. The resulting sequence was analyzed with 
the DNAStar (SeqMan) software package and verified on public domain databases such as 
the “National Centre for Biotechnology Information” (NCBI). 
 
 
3.2.1.12. Primer design 
The sense and antisense DNA primers were designed manually based on appropriate 
melting points (50°C to 65°C) and GC content. They were verified with the DNAStar 
(PrimerSelect, SeqMan, EditSeq) software package and synthesized at the “DNA core 
Facility” of the Max-Planck-Institute of Experimental Medicine. 
 
 
3.2.1.13. DNA amplification by employing polymerase chain reaction (PCR) 
The polymerase chain reaction permits the in vitro amplification of a specific DNA sequence 
(Mullis et al., 1986). DNA synthesis starts at two primers that flank the sequence to be 
amplified. One of them anneals to the sense and the other one to the antisense strand of the 
amplicon.  
The DNA polymerase of the thermophilic bacterium Thermus aquaticus (taq polymerase) 
catalyzes the reaction at 72°C and is stable at 95°C. DNA synthesis is carried out in a 
thermocycler (Thermocycler T3, Biometra) that changes temperatures between 95°C, the 
specific annealing temperature of the primers, and 72°C for the synthesis reaction. The 
reaction mixture contains the DNA template, primers dNTPs and the taq polymerase with 
corresponding salt and optimal pH conditions. Multiple reaction cycles are necessary to 
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obtain sufficient quantities of the DNA fragment for further studies. Standard PCR reactions 
were performed as following: 
 
1 µl DNA (100 pg to 100 ng) 
1 μl sense primer (10 pM) 
1 μl antisense primer (10 pM) 
2 μl dNTP mix (2 mM) 
2 μl 10x RedTaq buffer 
1 μl RedTaq polymerase (1 U/μl) 
12 μl ddH2O 
 
As the taq polymerase does not possess a 3’-5’ exonuclease activity (“proofreading”), and 
thereby introduces about 0.8 mismatches per 1 kb per amplification cycle. Therefore, the 
proofreading DNA polymerase of Pyrococcus furiosus (Pfu polymerase) was employed and 
the number of cycles was reduced, when necessary. To visualize the amplified PCR product, 
these were separated on an agarose gel. 
 
 
3.2.2. Generation of null-mutant mice 
 
 
3.2.2.1. DNA preparation for electroporation into embryonic stem cells 
150 µg of the targeting vector were linearized with the ClaI restriction enzyme ON at 37°C 
and this was confirmed by the electrophoretic separation of a little amount (5 µl) of the digest 
in a 0.8 % agarose gel. The linearized vector was purified by isopropanol precipitation and 
column filtration. In a 1:1 ratio the linearized vector and isopropanol were added, and the 
precipitated DNA fragments were pelleted by centrifugation at 13000 rpm for 10 min at RT. 
The resulting pellet was washed twice with 70 % ethanol, with a further centrifugation step 
between each washing. By air-drying the pellet at RT for 20 min, the traces of ethanol were 
removed, and then the pellet was dissolved in 80 μl of 10 mM Tris-HCl (pH 8.5) at 50ºC for 
30 min. The following column filtration purification was performed in C-30 columns (BioRad), 
according to the manufacturer’s protocol. The column tip had to be broken and then the 
columns were centrifuged at 2000 rpm for 3 min, to release the storage buffer. 80 μl of 
linearized DNA were added on the C-30 column and centrifuged at 2000 rpm for 3 min. The 
eluted fraction was collected in a microfuge tube. Than 40 μl of 10mM Tris-HCl (pH 8.5) were 
added onto the C-30 column and centrifuged at 2000 rpm for 3 min. The eluted fraction was 
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collected in the same microfuge tube as the previous. Finally to recover any remaining DNA, 
further 40 μl of 10mM Tris-HCl (pH 8.5) was added on the column and centrifuged at 2000 
rpm for 3 min. This fraction was collected in a clean microfuge tube and stored at -20ºC. The 
DNA concentration was measured spectrophotometrically and 1 μl was separated on a 0.8 % 
agarose gel to confirm the concentration and integrity of the DNA. Once that was assessed, 
the linearized fragment (~ 50 μg) was ready for the electroporation into ES cells. 
 
 
3.2.2.2. Electroporation and selection of ES cells 
One vial of frozen ES cells (5 · 106 cells) was plated on a 6 cm dish and incubated for 36 to 
48 hours at 37ºC and 5 % CO2. Cells were splitted on two 10 cm dishes and kept in culture 
for 2 to 3 days prior to electroporation. Thereby, sufficient cells 10 to 15 · 106 ES cells/plate 
(i.e. confluent plate) were available for various transfections. Several hours before the 
transfection, the culture medium was changed, as actively growing cells are a prerequisite for 
successful transfection. Cells were trypsinized (2 ml/dish) and spun down at 900 rpm for 5 
min. The cell pellet was resuspended in the medium, pre-plated on 10 cm dishes covered 
with gelatine, to get rid of feeders (fibroblast cells), and incubated at 37ºC for 45 min and 5 % 
CO2. The supernatant medium containing mainly ES cells, as feeders were attaching to the 
gelatin, was transferred to a 15 ml falcon tube. ES cells were spun down at 900 rpm for 5 min 
and the pellet was immediately resuspended in 1 ml of cold PBS. Cells were counted using a 
Neubauer chamber and the cell number was adjusted to about 10 to 14 · 106 cells/ml. From 
these ES cell suspension, 0.7 ml (i.e. 7 to 10 · 106 cells) was transferred to a microfuge tube 
and kept on ice. Then, 100 μl (0.5 μg/μl) of the linearized targeting vector DNA were added 
and mixed thoroughly. This mix was transferred to an electroporation cuvette (pre-cooled on 
ice) and was pulsed (240 V, 500 μF) with an electroporator (BioRad). After the pulse the 
cuvette was incubated on ice for 20 min. The cell suspension was then transferred to a fresh 
tube, 30 ml of ES cell medium were added and the cells were plated on three 10 cm dishes. 
After 24 hours the medium was changed and selection was started with G418 (f.c. 300 
μg/ml). Approximately at day 10 of selection large isolated ES cell clones were picked up. 
 
 
3.2.2.3. DNA isolation of ES cells 
When picking the ES clones, a fraction was kept for DNA recovery. These cells were pelleted 
by centrifugation at 13000 rpm for 10 to 15 min at RT, the supernatant was carefully 
aspirated out and the pellet was washed with 100 μl of sterile 1xDPBS. Cells were then 
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repelleted by centrifugation at 13000 rpm for 5 min at RT and the resulting pellet was 
resuspended in 50 μl of ddH2O. This cell suspension was kept at 95ºC for 10 min and 
centrifuged shortly to spin down the evaporated liquid. After cooling down on ice, cells were 
digested with 1 μl of proteinase K (20 μg/μl) at 56ºC for 30 min, with strong shaking. The 
lysed cells were then incubated at 95ºC for 15 min to heat inactivate the proteinase K, and 
were finally centrifuged shortly to evaporated liquid on the microfuge tube sides. 5 μl of these 
DNA preparations were used for PCR amplification. 
 
 
3.2.2.4. PCR amplification of ES cell DNA 
The ES cell DNA had to be amplified by PCR, for assessing if homologous recombination 
had taken place. Therefore, a nested PCR based screening strategy was employed. For 
establishing the primer pairs capable of efficient amplification of a homologous recombined 
target sequence and the PCR conditions, a control vector was used. This control vector had 
a homologous sequence 5’ to the short arm and lacked the 3’ long arm of the targeting 
vector. The nested PCR is a two-step reaction, were the amplification product of the outer 
primer pair is used as the template for the amplification reaction of the inner primer pair. The 
nested PCR amplification yielded a product of about 2.1 kb in the control vector and of 1.6 kb 
in homologous recombined ES cells, confirming that the homologous recombination had 
taken place. 
 
Nested external PCR: 
5 µl template ES cell DNA    94°C, 2 min 30 sec 
1.5 µl SE primer (10 pmol/μl)    56°C, 30 sec 
1.5 µl AS primer (10 pmol/μl)    72°C, 2 min 30 sec 
2 µl betain     94°C, 30 sec, 20 cycle repetition 
2 µl dNTP mix (2 mM)   56°C, 1 min 
4 µl 5xGoTaq buffer    72°C, 5min 
0.15 µl Go Taq polymerase   4°C  
0.1 µl Pfu turbo polymerase 
3.75 µl ddH2O 
 
Nested internal PCR: 
2 µl template of the external PCR reaction   94°C, 2 min 30 sec 
1.5 µl SE primer (10 pmol/μl)    56°C, 30 sec 
1.5 µl AS primer (10 pmol/μl)    72°C, 2 min 30 sec 
2 µl betain     94°C, 30 sec, 36 cycle repetitions 
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2 µl dNTP mix (2 mM)   56°C, 1 min 
4.4 µl 5xGoTaq buffer   72°C, 5 min 
0.15 µl Go Taq polymerase 
0.1 µl Pfu turbo polymerase 
8.35 µl ddH2O 
 
 
3.2.3. Protein biochemical methods 
 
 
3.2.3.1 Preparation of protein lysates from cell cultures 
Primary cortical neurons (plated ~1 · 106 cells) kept in culture for 2 DIV on 10 cm dishes were 
lysed in RIPA buffer to obtain proteins for subsequent immunoblot analysis. The dish was 
washed once with cold PBS, 200 μl of RIPA buffer was applied and cells were scraped from 
the dish with a cell-scraper. The obtained cells were placed into a microfuge tube and left on 
ice for 20 min to lyse. Cell lysates were centrifuged at 4ºC for 20 min at 13000rpm maximum 
speed, to pellet the undigested material. The supernatant containing the soluble proteins was 
transferred into a new tube and kept at -20ºC. The pellet containing the cell debris and 
unsolubilized material was as well stored at -20ºC.  
 
 
3.2.3.2. Preparation of a CNS-myelin enriched fraction 
Mice were sacrificed by spinal cord dislocation and decapitated. The brains were removed, 
collected and homogenated in 0.32 M sucrose. This preparation of the CNS-myelin enriched 
fraction was according to Norton & Poduslo (1973). All centrifugation steps were performed 
in a SW28 rotor in a Beckman ultracentrifuge. The brains were homogenated with an Ultra-
Turrax in 0.32 M sucrose and than layered over a 0.85 M sucrose solution in centrifuging 
tubes (Beckmann). It was then centrifuged at 23800 rpm for 30 min and the interphase was 
collected with a Pasteur pipette and put into a clean tube. Then the interphase was washed 
with dH2O, by filling the tubes with dH2O and centrifuging at 23800 rpm for 15 min. The 
supernatant was discarded, the pellet was resuspended in dH2O while vortexing. Then the 
first osmotic shock took place, by filling the tubes with dH2O, incubating for 10 min and 
centrifuging at 9500 rpm for 15 min. For the second osmotic shock, the resulting pellet was 
resuspended in dH2O and centrifuged again at 9500 rpm for 15 min. The pellet was than 
resuspended in 0.32 M sucrose and layered over 0.85 M sucrose in a clean centrifuge tube. 
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This was centrifuged at 23800 rpm for 30 min. The second interphase is collected than, and 
washed with water, by filling the tubes with dH2O and centrifuging at 23800 rpm for 15 min. 
The resulting pellet was the purified myelin fraction, which was resuspended in TBS with 
protease inhibitors, aliquoted and kept at -80°C until further use.  
 
 
3.2.3.3. Protein concentration measurement by Lowry assay 
The protein concentrations were assessed in 96-well plates (flat bottom) with the “DC Protein 
Assay kit” (BioRad) according to the manufacturer’s 'microplate assay' protocol, which is 
based on the Lowry assay (Lowry et al., 1951). The assay is based on two subsequent 
reactions between the proteins and a copper in alkaline medium, followed by the reduction of 
the Folin reagent that produces several reduced species of a characteristic blue colour with a 
maximum absorbance at 750 nm. The colour development is primarily due to the oxidation of 
the amino acids tyrosine and tryptophan, and to a lesser extent, cystine, cysteine, and 
histidine. The absorbance was measured at 650 nm in a microtitre plate reader. 
 
 
3.2.3.4. SDS-polyacrylamide gel electrophoresis  
The separation of proteins was performed using the discontinuous SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) of the Mini-Protean-3 system (BioRad), based on the 
description of Laemmli (1970). The chamber and gels were assembled as described by the 
manufactures protocol. A separating gel of desired thickness and percentage of acrylamide 
was layered with isobutanol. Before casting a stacking gel, the residual alcohol was removed 
and the future interphase between the two gels was rinsed twice with dH2O. 5 μl of 
prestained Page Ruler Plus (Fermentas) was loaded on each gel as a molecular weight 
standard and to monitor the electrophoresis. A maximum of 40 μl sample was loaded in a 
single pocket and the gels were run with a constant current of 30 mA per gel, and a 
maximum voltage of 150 V. Gels were subjected to immunoblotting, once the bromophenol 




The proteins were transferred from the SDS-gel onto a PVDF membrane (pore size 0.45 μm, 
Amersham/Millipore) by electrophoresis with the Invitrogen blotting apparatus (based on the 
original description of Towbin et al., 1979). PVDF membranes were activated for 30 sec in 
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methanol and incubated 5 to 15 min in transfer buffer. Blotting paper and blotting pads 
presoaked in transfer buffer were assembled according to the manufacturer’s protocol, 
although the blotting buffer differs from the manufacturers recommended. Proteins were 
transferred at a constant voltage of 38 V and a maximum current of 275 mA, for 1 hour at 
RT. Afterwards, the immunodetection of the proteins on PVDF membranes was performed. 
The membranes were rinsed briefly in TBS and blocked for at least 1 hour at RT in blocking 
buffer (5 % non-fat dry milk in TBS). Primary antibody diluted in blocking buffer was applied 
ON at 4°C. After four washes in TBS-T (0.05 % Tween-20 in TBS), HRP-conjugated 
secondary antibodies were applied for at least 1 hour, followed by four washes with TBS-T. 
Membranes were exposed using the Enhanced Chemiluminescence Detection kit 
(PerkinElmer), according to the manufacturer’s instructions. ECL photographic films 
(Hyperfilm™, Amersham Biosciences) were used to expose the membranes. The time of 
exposure varied depending on the signal intensity. To reprobe the same membrane with a 
second antibody, the membrane was incubated with stripping buffer for 1 hour at 55°C with 
rigorous shaking. After one wash with TBS-T, the membrane was incubated in blocking 
buffer for 30 min before probing with the second primary antibody.  
 
 
3.2.3.6. Silver staining 
The silver staining was performed according to the modified protocols of Blum et al. (1987) 
and Mortz et al. (2001). The proteins were separated by SDS-polyacrylamide gel 
electrophoresis (section 3.2.3.4.) and than the gel was incubated in different solutions. All 
steps were performed on a shaking table. The silver staining was performed according to the 
following incubation steps: fixed in 40 % ethanol, 10 % acetic acid for 1 hour, washed twice 
with 30 % ethanol for 20 min each, and once with dH2O for 20 min, sensitized in sodium 
thiosulfate for 1 min, rinsed trice with dH2O for 20 sec each, impreganated with 0.2 % silver 
nitrate, 0.05 % formaldehyde solution (37 %) for 20 min and rinsed again trice in dH2O for 20 
sec. Then the development took place, and this step needed to be performed under visual 
inspection for evaluating when the staining is sufficient. The gel was incubated with 3 % 
sodium carbonate, 0.05 % formaldehyde solution (37 %) for 2 to 10 min, and once the 
staining was prominent enough, the gel was rinsed in dH2O for 20 sec and the staining 
reaction was stopped by incubation with 5 % acetic acid for 10 min. Finally, the gel was 
washed trice with dH2O for 10 min each and could be stored without drying out for long time 




3.2.4. Animal breeding 
The TSPAN2null mice were generated in C57BL/6 ES cells and a backcrossing was therefore 
not necessary. The PLPnull, GPM6Anull, GPM6Bnull, GPM6Anull*GPM6Bnull mice had already 
been bred into the C57BL/6 background for more than ten generations using mice from the 
breeding colony of the Max-Planck-Institute of Experimental Medicine. And consequently the 
TSPAN2null*PLPnull did also not require specific backcrossing. Wild-type animals were 
obtained from the breeding colony of the Max-Planck-Institute of Experimental Medicine. All 
animals used for this work were kept and treated in accordance with the guidelines for animal 
welfare of the Max-Planck-Institute of Experimental Medicine, approved by the German 
Federal State of Lower Saxony.  
 
 
3.2.5. Cell culture 
 
 
3.2.5.1. Primary cortical neuron cultures 
Primary cortical neurons were prepared form brain hemispheres of E15 to E17 embryos. 
Briefly, the dissect hemispheres were removed from their meninges on HBSS+ and 
transferred into a 15 ml Falcon tube with HBSS+. This medium was removed and 1 ml of a 
1:1:1 dilution of papain (20 U/ml), HBSS and DNase was added and incubated at RT for 6 
min. The reaction was stopped by adding 1 ml of 10 % FCS in HBSS. HBSS was added until 
reaching 10 ml and the cells were centrifuged at 900 rpm for 5 min. The supernatant was 
removed, 2 ml of Neurobasal complete medium were added and the cells were carefully 
dissociated with a fire-polished Pasteur pipette. A 1:10 dilution was performed to determine 
the cell number in a Neubauer chamber. The appropriate cell were plated onto 10 cm dishes 
(5 · 106 cells) or onto 24-well plates (5 · 104 cells/well) (Falcon) containing PLL-coated (0.2 
mg/ml, 37°C for at least 30 min) glass coverslips, and cultured at 37°C with 5 % CO2.  
 
 
3.2.5.2. Growth cone collapse assay 
The “growth cone collapse assay” was performed on primary cortical neurons, cultured for 2 
DIV of wild-type, GPM6Anull, GPM6Bnull and GPM6Anull*GPM6Bnull mice. The assay is based 
on the protocol applied by Knöll et al. (2006). Briefly, primary cortical neurons were cultured 
for 2 DIV with 500 µl medium in 24-well plates. The ephrin-A5-Fc (1 µg/ml) was preincubated 
with the anti-human IgG (10 µg/ml), as well as the recombinant Fc (1 µg/ml) with anti-human 
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IgG, which serves as a control condition, at RT for 30 min. These were added to the cultures, 
mixed carefully and incubated for 30 to 45 min at 37°C, 5 % CO2. When the increased 
ephrinA5 dose was applied, double amounts of ephrinA5 were preclustered to the anti-
human IgG. Than, cells had to be fixed with 4 % PFA including 10 % sucrose in a very fast 
manner, by adding the fixative directly to the side of the well and including no prior washing 
step, as these could abolish the effect of the collapse agents. After 5 min, the PFA/sucrose 
was refreshed, and 5 min later washed twice with PBS. The cortical neurons were than 
immunostained against tubulin and F-actin to visualize the collapse effect. The collapse was 
assessed on the axonal growth cones and defined as the absence of a lamellipodium. 
 
In order to quantitative assess the respond to the growth cone collapse assay, cortical 
neurons were randomly imaged with a Leica SP2 confocal microscope, with a 63x oil 
objective. For each genotype n = 3 was used and ~ 75 growth cones were quantified per 
condition. The images were analyzed using the ImageJ software. The collapse was 
assessed on the axonal growth cones and defined as the absence of a lamellipodium. The 
statistical significance of the differences between experimental groups was assessed by 




Immunostainings were carried out at the time mentioned in the experiment, and all steps 
were performed at RT. Cortical neurons grown on PLL-coated coverslips were washed once 
(unless other stated) with PBS and fixed for 10 min with 4 % PFA and 10 % sucrose. Cells 
were then washed trice for 10 min in PBS, permeabilized for 5 min with 0.1 % TritonX-100 in 
PBS and washed twice with PBS. They were than blocked for 30 min in blocking solution (2 
% BSA in PBS) and the primary antibody was applied for 1 hour in blocking solution. 
Afterwards they were washed trice with PBS and the fluorochrome-conjugated secondary 
antibody were applied and kept in darkness for 1 hour. When phalloidin-rhodamin was used, 
it was added to the secondary antibody dilution. After four washings, including 4',6’-
diamidino-2-phenylindole (DAPI) in the second-last one, the coverslips were rinsed in dH2O 




3.2.7. Histology and immunohistochemistry 
 
 
3.2.7.1. Perfusion and fixation of mouse tissue  
Mice were deeply anaesthetized by injecting 2.5 % avertin (0.017 ml/g of body weight) 
intraperitoneally. Once anaesthetized, the mice were washed with 70 % ethanol on the 
stomach and the skin was removed from the ventral side. A transversal cut was made just 
below the diaphragm and slowly opened until the heart was visible. A 27-gauge needle was 
inserted into the left ventricle and, immediately after starting the perfusion, a small incision 
was made in the right auricle to allow the blood to flow out of the body. Perfusion was carried 
out with HBSS and changed from HBBS to fixative (4 % PFA in PB). The perfusion was 
carried out with ~ 50 ml of fixative. The brain were removed carefully and collected into vials 
with fixative and stored in it ON at 4°C and then in 1 % PFA/PBS until further use.  
 
 
3.2.7.2. Paraplast impregnation and embedding of the tissue  
After post-fixation, the tissue was washed 3 to 4 times with PBS, the brains were cut into half 
and transferred into plastic chambers for dehydration and paraplast impregnation. The 
dehydration consisted in incubating the brains in the following solutions: 50 % ethanol for 1 
hour, twice in 70 % ethanol for 2 hours, twice in 96 % ethanol for 1 hour and twice in 100 % 
ethanol for 1 hour each. Then, they were incubated in isopropanol for 1 hour, twice in xylol 
for 2 hours and the tissues were impregnated with paraplast at 60ºC for 2 hours. Finally, the 
tissue was embedded in molten paraplast and left to harden. Blocks were removed from the 
moulds and could be stored stably for years. 
 
 
3.2.7.3. Haematoxylin-Eosin (HE) staining  
From the paraffinized blocks, 7 μm thick sections were cut using a microtome. The sections 
were floated on a warm water bath (42°C), placed on positively charged glass slides and 
then dried ON at 37°C. The sections were then incubated at 60°C for 10 min before being 
deparaffinized and rehydrated in the following steps: twice in xylol and once in 
xylol/isopropanol (1:1) for 10 min each, then, 100 % - 90 % - 70 % - 50 % ethanol for 5 min 
each and were than rinsed in dH2O. The sections were incubated with 0.1 % haematoxylin 
for 5 min staining the basic cell nuclear compartment blue. After a wash with dH2O, the 
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sections were dipped in a HCl-alcohol solution once for 5 to 10 sec and then in Scott’s 
solution for 5 min. They were shortly rinsed with dH2O, counterstained with 0.1 % eosin for 3 
to 5 min and then rinsed with dH2O. Sections were dehydrated by incubating them in 
increasing alcohol concentrations (50 %, 70 %, 90 %, and 100 %) for 2 min each, then in 
xylol/isopropanol (1:1) and twice in xylol for 5 min. Finally, they were mounted with ‘Eukitt’ 
(Kindler GmbH).  
 
 
3.2.7.4. DAB-based immunodetection on paraffin sections  
The sections were processed as above (section 3.2.7.3.) until rehydration, when they were 
incubated for 5 min in citrate buffer before being “cooked” for 10 min in boiling citrate buffer 
in a microwave. After this, the sections were left in the citrate buffer for about 20 min to cool 
down and subsequently rinsed in Tris buffer/2 % milk for 5 min. Endogenous peroxidases 
were inactivated by incubating the sections with 100 μl of 3 % hydrogen peroxide for 5 min. 
Then, the sections were incubated with 100 μl of goat-serum diluted in PBS/BSA (1:5) for 20 
min at RT before proceeding with the 100 μl of the primary antibody diluted in PBS/BSA. 
After an ON incubation at 4°C, the sections were washed with Tris buffer/2 % milk and 
incubated with 100 μl of bridging antibody, i.e. biotinylated secondary antibody (Dako) for 10 
min. They were then rinsed with Tris buffer/2 % milk and probed with 100 μl of tertiary 
antibody, i.e. Horseradish Peroxidase streptavidin complex (Dako), by incubating the 
sections for 10 min. They were then rinsed with the Tris buffer and incubated with 100 μl of 
DAB for 10 min. Finally, the sections were rinsed twice with dH2O for 5 min each and 
counterstained for 30 sec with haematoxylin following the steps until mounting (section 




3.2.8. Confocal and light microscopy  
The light microscopic observations were performed on a Zeiss Axiophot microscope using 
the following objectives: 4x (achroplan, 4x/0.10), 10x (achroplan, 10x/0.30) and 20x (plan-
neofluar, 20x/0.50) and the images were captured by a Kappa camera system (Kappa opto-
electronics GmbH, Gleichen, Germany). The images were taken with the Kappa Image Base 
Software (version 2.7.2.). 
 
Fluorescent images were captured on a Leica TCS-SP2 confocal microscope (Leica 
Microsystems Heidelberg Gmbh, Germany) with a 63x (plan-apochromat, 63x/1.4) oil 
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objective. For final analysis, captured Leica images were exported as TIF, and analysed and 
processed with the Leica Confocal Software (LCS, version 2.61) and ImageJ software 




3.2.8.1. In vivo imaging of cortical neuron growth cones 
For the in vivo imaging of cortical neuron growth cones, the cells were plated on 8-well glass 
slides (Ibidi GmbH) to allow the confocal imaging on them. Growth cones were imaged for 10 
min, taking one image every 3 sec, thereby resulting in a video of 201 frames. A 40x oil 
objective was used and the 633 nm laser was utilized for the reflection microscopy.  
The images were further analysed with the ImageJ software. The images were processed as 
following: a 2 pixel Gauss filter was applied, the images were thresholded and by differences 
in the intensity levels they areas were classified into “adhesive” and “non-adhesive”. For the 






Figure 7. Evaluation of the in vivo motility of cortical neuron growth cones. 
In each movie of the neuronal growth cones, the first frame was subtracted from the second, the second from 
the third, etc. Thereby the retraction between each frame could be evaluated as positive values and the 
extension as negative values.  
In each movie, the first frame (binarized after subtracting the background) was subtracted 
from the second, the second from the third, etc. Thereby the retraction between each frame 
could be evaluated as positive values and the extension as negative values. This allowed 
assessing the motility of these growth cones.  
 
 
3.2.9. Statistical analysis 
The statistical analyses have been performed with the Microsoft Office Excel 2003 and the 
SPSS 13.0 software. Briefly, the Student’s t-tests were applied to compare the mean values 
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of quantitative variables. The chi-square tests were applied in order to determine whether the 
frequency counts en each category were equally distributed. The ANOVA and the ANOVA 
with repeated measurements were performed to compare the variances. In the case of the 
ANOVA with repeated measurements, the sphericity could not be assumed and thereby the 









4.1. M6 Proteolipids in neuronal cell process formation 
The neuronal proteolipids M6A and M6B are transmembrane proteins highly expressed in 
the neurons of the CNS (Huminiecki et al., 2003) and located throughout the brain (Baumrind 
et al., 1992; Yan et al., 1996). Acute antibody applications or over- and underexpression 
have implicated these proteins in neurite outgrowth (Lagenauer et al., 1992; Zhao et al., 
2008) and filopodia formation (Alfonso et al., 2005; Fernández et al., 2010), but little is known 
about their function in vivo or about the consequences of their chronic lack. 
 
 
4.1.1. Localization of M6A and M6B on cortical neurons 
To characterize the expression of M6A and M6B in the culture system that has been 
subsequently used for functional investigations, immunocytochemical analysis was 
performed on wild-type primary cortical neurons of embryonic day 17 (E17) old mice 
embryos at 3 days in vitro (DIV). The ex vivo culture system was chosen, because it allows a 
simplified approach to study the importance of neuronal proteolipids in the neuronal biology.  
 
The cortical neurons were immunostained using antibodies against M6A and M6B. The 
staining revealed the presence of a mixed population of cortical neurons expressing the 















Figure 8. Wild-type cortical neurons 
expressing M6A and M6B.  
Confocal image illustrating the 
immunocytochemical localization of 
M6A (red) and M6B (green) proteins in 
cultured cortical neurons prepared from 
E17 mice and maintained for 3 DIV. 
Most cortical neurons express both 
proteins, but their expression levels 
vary. Scale bar = 20 µm. 
  
Distinct neurons differ regarding their staining towards M6A and M6B (Fig.8). Most cortical 







Figure 9. Types of wild-type cortical neurons according to the M6-protein abundance.   
Mouse cortical neurons (E17) were cultured for 3 DIV, immunostained against M6A (red) and M6B (green) and 
confocal images were taken. There is a mixed population of neurons expressing the neuronal proteolipids. There 
are cells expressing similar levels of both proteins (A), others expressing mainly M6A (B) or M6B (C, D). There 
are two subtypes of cortical neurons regarding their M6B expression pattern, either M6B has an overall broad 
localization in the cell (C) or it localizes mainly to the outer plasma membrane (D). Scale bars = 15 µm.  
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 Thereby there are cortical neurons that do express predominantly M6A (Fig. 9B) or M6B 
proteolipid protein. Interestingly, in the case of neurons expressing predominantly M6B, there 
are two subtypes of cortical neurons regarding this expression pattern: some neurons 
express M6B in a broad manner all over the cell (Fig. 9C), whereas in other neurons M6B is 
confined mainly to the external plasma membrane of the cell (Fig. 9D). In the cortical 
neurons that do express similar levels of both proteins, these co-localize extensively in axons 
and dendrites and partially in the somata, where M6B is more abundant (Fig. 9A). The M6A 
as well as the M6B staining demonstrates the presence of the neuronal proteolipids on all 
neurite processes, therefore in axons as well as in dendrites, with no difference in their 
expression levels between these. These results validate this culture system for the study of 
neuronal M6 proteins in neuronal development. 
 
 
4.1.2. Subcellular localization of M6A and M6B on cortical neurons 
To elucidate the localization of the neuronal proteolipids in more detail, co-localization 
studies were accomplished. It is known that tubulin as well as F-actin are major components 
of neurons, and that they define neuronal structures. Tubulin is mainly found in the axonal 
and dendritic shafts, while F-actin is mainly found in the peripheral growth cone regions 
(Dent et al., 2010).  
 
To investigate the subcellular localization of the neuronal proteolipids M6A and M6B, 
immunocytochemistry was performed to observe their co-localization regarding tubulin and 
F-actin. For these, the antibody Tuj-1 (against neuron-specific class III beta-tubulin) and the 
toxin phalloidin that binds to F-actin were used. These experiments were performed on wild-
type cortical neurons of E15 old mice embryos at 3 DIV.  
 
M6A as well as M6B are mainly expressed in tubulin rich compartments (Fig. 10A, B) 
including the axon and dendrites. When comparing their localization with F-actin, M6A co-
localizes with F-actin positive structures such as the neurite tips and growth cones, but is 
also prominently detected at F-actin free membrane extensions (Fig. 10C). The M6B 
expression is confined to F-actin-rich domains, but not outside these (Fig. 10D). Thereby, 












Figure 10. Subcellular localization of M6A and M6B on wild-type cortical neurons regarding tubulin 
and F-actin. 
Immunocytochemistry was performed on mouse cortical neurons (E15) at 3 DIV and confocal images were 
taken. M6A (A) and M6B (B) localization in contrast to neuron-specific class III beta-tubulin (Tuj1) revealed 
that M6A as well as M6B co-localize with tubulin-rich structures. M6A also co-localized with F-actin positive 
regions (C), but was also found on F-actin free membrane extensions (arrow). M6B was also found in F-
actin positive regions (D), but not extending into F-actin free membrane extensions (arrowhead). Images in 





4.1.3. M6A defines F-actin free membrane protrusions 
To further investigate the localization of M6 proteins at F-actin free membrane extensions a 
more detailed analysis was performed. According to the current knowledge, lamellipodia and 
filopodia have a high content in F-actin, and filopodia contain by abundance mainly F-actin, 
which also gives them their finger-shaped structure (Dent et al., 2010). 
 
Wild-type cortical neurons of E17 old mice embryos were cultured, fixed at 2 DIV and cells 
were stained against M6A or M6B and against F-actin with the toxin phalloidin. Confocal 
imaging that included not only the conventional laser-driven signal, but also simultaneous 
reflection confocal microscopy was performed. This allowed the examination of the signals 
from the immunocytochemistry, as well as the membrane surface and outer membrane 
demarcation. This was essential for being able to define outer tubules and membrane 
extensions, on which the presence or absence of F-actin and M6A or M6B were analysed.  
 
On primary cortical neurons stained against M6A and F-actin co-localization was found on 
many tubular structures (filopodia) as well as on growth cone tips. However, there were 
frequent cases in which M6A was found in F-actin free outward tubules that clearly showed a 
membrane continuation at the reflection microscopy level, indicating that the M6A-positive F-
actin-negative outer membrane tips were in contact with the full cell membrane (Fig. 11). In 
some neurite tips the majority of the process tips were M6A-positive and F-actin-negative 
(Fig. 11A). However, there were also cells in which there was diversity regarding the type of 
neurite tips. Some were positive for M6A and F-actin (Fig. 11B star), while close by others 
lack F-actin all over the process (Fig. 11 open arrow). Additionally, there were cases in which 
M6A and F-actin were both present in one subcompartment, while in the other compartment 
there was M6A labelling in the absence of F-actin. Hence, in particular in small processes the 
presence of M6A was found (Fig. 11B arrow). In some cases, process-ending tips showed 
M6A labelling and no F-actin one, thereby M6A was defining the end of these tip (Fig. 11B 
arrowhead). M6A-positive F-actin-negative membrane extensions were various in length 
(Fig. 11A arrow, B arrow and open arrow). There were also cases in which the M6A-positive 
membrane process extended more than 10 µm without the presence of F-actin (Fig. 11C). 
Besides there were also neurons in which membrane flattened extensions lack F-actin but 











Figure 11. M6A defines F-actin free membrane protrusions.
E17 mouse cortical neurons were immunostained at 2 DIV against M6A (cyan) and F-actin (phalloidin toxin, 
red). Confocal microscopy and simultaneous reflection microscopy (gray) were performed to visualize the 
immunocytochemistry and the outer cell membrane delimitation. M6A co-localizes with F-actin at membrane 
extensions and growth cone regions, but is also found at membrane extensions that lack F-actin. In some 
neurites all membrane outer tips are M6A-positive and F-actin-negative (A, arrow). While in other membrane 
extensions there are a variety of events: M6A and F-actin positive protrusions (B, star); M6A and F-actin-
positive extensions up to a position from which only M6A is present at the periphery, either at complete tips (B, 
arrow) or at final endpoints of the tip (B, arrowhead); as well as entire M6A-positive and F-actin negative 
processes (B, open arrow). The extension of the neurite tip at the absence of F-actin can extend more than 10 
µm (C, arrow). There are also flat membrane extensions that are M6A-positive and F-actin negative (D, arrow). 
Scale bars = 5 µm. 
Taken together, M6A defines a novel structure, as F-actin has been assumed “to compose 
the core of filopodia” (cited after Dent & Gertler, 2003). Consequently the M6A-rich domain in 
F-actin free membrane extensions of neuronal growth cones defines novel F-actin free M6A-
rich membrane protrusions.  
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On the other hand, this is not the case for M6B. M6B was always confined to F-actin-rich 
regions and did not define F-actin free domains at the cell tips (Fig. 12). Very seldom M6B 
seemed present in F-actin free membrane tips, but this could be excluded upon more careful 
microscopic assessment (Fig. 12A arrowhead). Occasionally there were membrane tips that 
lacked either M6B as well as F-actin staining (Fig. 12 arrow), most likely these protrusions 
were M6A-positive. In general the majority of the tips were positive for M6B as well as for F-








Figure 12. M6B does not define F-actin free membrane protrusions.
Mouse cortical neurons (E17) were immunostained at 2 DIV against M6B (green) and F-actin (phalloidin toxin, 
red). Conventional confocal microscopy and simultaneous reflection microscopy (gray) were preformed to 
visualize the staining and the outer cell membrane delimitation. M6B does co-localize with F-actin at membrane 
extensions and growth cone regions, but is not found at membrane extensions that lack F-actin. In some neurite 
tip M6B seemed present without an F-actin co-labelling, but upon more careful examination this was excluded 
(A, arrow). Some tips lack M6B as well as F-actin staining (B, arrow). Most of the membrane extensions were 
positive for M6B as well as for F-actin (C, arrow). Scale bars = 5 µm. 
 
Accordingly, M6A does define F-actin free membrane protrusions while M6B does not. And 
in wild-type cortical neurons, essentially all membrane protrusions express the neuronal M6 
proteolipid proteins.  
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4.1.4. Altered growth cone morphology in Gpm6anull*Gpm6bnull mice 
Actin and tubulin define two different compartments in neuronal growth cones. This 
compartmentalization is known since long. There are MTs (thereby tubulin) in the axon shaft 
as well as in the centre of the neuronal growth cone. In the growth cone periphery, the 
lamellipodia, there are only few MTs but mainly a network of F-actin filaments. Finally, at the 
growth cone tips, the filopodia, F-actin is found mostly in them, hence also defining them 
(see Fig. 2, Dent & Kalil, 2001; Dent & Gertler, 2003). Sometimes, in pausing growth cones, 
it can occur that tubulin reaches partially into the actin domain (Dent et al., 2010).  
 
As a high expression of the M6 proteins had already been observed in cortical neuronal 
growth cones as well as a distinct localization of the M6A proteolipid protein regarding F-
actin at the growth cone tip, an investigation involving the actin and tubulin 
compartmentalization was performed. For this purpose, primary cortical neurons of E17 wild-
type as well as Gpm6anull*Gpm6bnull mice were cultured and immunostained at 2 DIV against 
tubulin (Tuj1; Neuron-specific class III beta-tubulin) and F-actin (phalloidin). For each 
genotype (wild-type or Gpm6anull*Gpm6bnull mice) the analysis was performed on cortical 
neurons deriving form four different embryos (n = 4) at E17, with ≥ 15 neurons per individual. 
Overall 63 wild-type and 61 Gpm6anull*Gpm6bnull neurons were analysed, resulting, 
respectively, in a total of 167 and 137 analyzed growth cones.  
 
To evaluate the different localization of tubulin and F-actin, three categories were 
established: (1) tubulin and F-actin are together in one compartment, superimposed or 
partially superimposed, (2) tubulin and F-actin are separated into two compartments, as 
described in literature, being F-actin at the tips, and (3) tubulin is expressed at the end of the 
tips, beyond F-actin. For increased precision, it was distinguished between the growth cone 
or tip of the axon –or longest neurite in case of doubt– or the growth cone or tip of the 
remaining neurites. As expected, wild-type cortical neurites fell mainly into category two 
(Table 1). This is the case for the axonal growth cones (83 %) as well as for the tips of the 
remaining neurites (88 %). Some growth cones could be classified into the category of 
tubulin and F-actin being partially superimposed (17 % for axonal growth cone, 11 % for the 
remaining), while a localization of tubulin distal to F-actin is extremely unusual (0 - 1 %) in 
wild-type cortical neurons. Interestingly, this was very different in the cortical neurons of the 
Gpm6anull*Gpm6bnull mice (Table 1). Indeed, the majority of their growth cones were 
categorized into the group of tubulin being superimposed over F-actin (57 % in axonal growth 
cones, 56 % in remaining growth cones). Surprisingly, there were frequent growth cones in 






  Axonal GC Remaining GCs All GCs 
Cat. WT dKO WT dKO WT dKO 
1 11 (17%) 35 (57%) 18 (11%) 77 (56%) 29 (13%) 112 (57%) 
2 52 (83%) 19 (31%) 147 (88%) 38 (28%) 199 (87%) 57 (29%) 







The following bar diagram (Fig. 13) shows the grouping of the growth cones of wild-type as 
well as Gpm6anull*Gpm6bnull mice according to the three categories (see above). There is an 
obvious difference regarding the distribution over the categories between the genotypes in all 
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Table 1. Neuronal growth cones classification according to their F-actin and tubulin 
compartmentalization, into three categories. 
Proportion of wild-type (WT) and Gpm6anull*Gpm6bnull (dKO) growth cones of the axon (Axonal GC) as well as 
the remaining growth cones (Remaining GCs) and the totality of the growth cones (All GCs), according to three 
categories: (1) tubulin and F-actin in one compartment, (2) tubulin proximal to F-actin localization, and (3) 
tubulin distal to F-actin localization. Display of the absolute numbers and the percentages in parenthesis. The 
star designates categories that excluded a statistical analysis.  
Figure 13. Classification of the neuronal growth cones according to three categories. 
Evaluation of the tubulin and F-actin localization in 2 DIV cultured primary cortical neurons of E17 mice. 
Percentage of wild-type (WT) and Gpm6anull*Gpm6bnull (dKO) growth cones of the axon (Axonal GC) as well 
as the remaining growth cones (Remaining GCs) and the totality of the growth cones (All GCs), according to 
three categories: (1) tubulin and F-actin in one compartment, (2) tubulin proximal to F-actin localization, and 
(3) tubulin distal to F-actin localization.  
The fact that the third category of growth cones (with tubulin at the most distal endpoint) was 
only found in Gpm6anull*Gpm6bnull cortical neurons impeded a statistical analysis, as the data 
points were zero or one in the wild-type (Table 1, star), thereby not fulfilling the minimal 
requirement for a meaningful statistical analysis.  
Consequently, to perform a statistical analysis the categories were merged, so that there 
were two remaining groups: (1) tubulin and F-actin in one compartment, partially 
superimposed or tubulin at the distal endpoint of the tip, and (2) tubulin and F-actin in two 
 65
separated compartments (with F-actin at the distal end). Briefly, merging the prior category 







Table 2. Neuronal growth cones classification according to their F-actin and tubulin 
compartmentalization. 
Proportion of wild-type (WT) and Gpm6anull*Gpm6bnull (dKO) growth cones of the axon (Axonal GC) as well as 
the remaining growth cones (Remaining GCs) and the totality of the growth cones (All GCs), according to two 
categories: (1) tubulin and F-actin in one compartment, superimposed or with tubulin at the distal endpoint, and 
(2) tubulin proximal to F-actin localization. Display of the absolute numbers and the percentages in parenthesis.  
 Axonal GC Remaining GC All GCs 
Cat. WT dKO WT dKO WT dKO 
1 11 (17%) 42 (69%) 20 (12%) 99 (72%) 31 (13%) 141 (71%) 






On this dataset it was possible to perform a chi-square test comparison of the frequencies of 







Table 3. Chi-square comparison of frequencies of classification of neuronal growth cones according to 
their F-actin and tubulin compartmentalization. 
Representation of the result of the statistical analysis of the comparison of tubulin and F-actin localization on 
neuronal growth cones of wild-type and Gpm6anull*Gpm6bnull mice, according to two categories. Either tubulin 
and F-actin are in the same compartment, or into two different ones, with F-actin at the distal tip. Chi-square test 
performed on data resulting from n = 4 per genotype with ≥ 15 neurons per n, with a total of 167 and 137 growth 
cones, respectively. It is shown the Pearson Χ2 statistic (Pearson Χ2), the degrees of freedom (df) and the P-
value (P) for each comparison.  
 Pearson Χ2 df P 
Axonal GC 33.447 1 7.325 · 10-9 
Remaining GCs 114.825 1 8.597 · 10-27
All GCs 147.547 1 5.960 · 10-34
 
The result of the chi-square test demonstrates a very highly significant difference between 
wild-type and Gpm6anull*Gpm6bnull cortical neurons regarding the distribution of tubulin and F-
actin at the growth cones. No matter if the focus is on the growth cones or tips of the axons 
or the dendrites (Fig. 14). There is a very clear difference in all the neurite tips. In the 
Gpm6anull*Gpm6bnull cortical neurons it is significantly more frequent that tubulin is partially or 
totally superimposed over the F-actin compartment, or beyond the limits of the F-actin 
localization. This is a very profound breakage of the normal growth cone morphology, as 
tubulin and F-actin define the regions (morphologically and functionally) of the neuronal 
growth cone in a very distinctive manner.  
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Figure 14. Classification of the neuronal growth cones according to two categories. 
Evaluation of the tubulin and F-actin localization in 2 DIV cultured primary cortical neurons of E17 mice. 
Percentage of wild-type (WT) and Gpm6anull*Gpm6bnull (dKO) growth cones of the axon (Axonal GC) as well 
as the remaining growth cones (Remaining GCs) and the totality of the growth cones (All GCs), according to 
two categories: (1) tubulin and F-actin in one compartment superimposed or tubulin at the outer tip or (2) 
tubulin proximal to F-actin localization. There is a very highly significant difference (P<0.001) regarding this 
two categories between the WT and dKO growth cones of the axons, as well as the dendrites.  
An example of this altered growth cone morphology –defined by the localization of tubulin 








Figure 15. Altered growth cone morphology in Gpm6anull*Gpm6bnull mice. 
E17 cortical neurons were cultured for 2 DIV and stained against tubulin (Tuj1 antibody) and F-actin (Phalloidin 
toxin). The overview shows a normal F-actin-tubulin localization on the full cell level, but this is different when 
focusing at the growth cones. The wild-type (WT) growth cones (A) exhibit a defined and separated F-actin and 
tubulin localization. But the growth cones of the Gpm6anull*Gpm6bnull (dKO, B) show a strong overlap of tubulin 
and F-actin. Tubulin partially localizes to the F-actin domain, without having a complete overlap (arrow) with F-
actin. Some regions contain more tubulin, others more F-actin. Scale bars = 5 µm. 
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As depicted in the representative example of Fig. 15, in Gpm6anull*Gpm6bnull cortical neurons 
the extension of the tubulin compartment into the normally exclusive F-actin domains does 
not occur with an absolute overlap. Although tubulin covers the majority of the F-actin-
positive regions, it occurs in a specific and partially exclusive manner. There are tubulin-
positive processes that lack the same F-actin distribution (Fig. 15, arrow). This also provides 
evidence that this observation is not due to a microscopy artefact. 
 
Consequently, there is an alteration of the normal F-actin and tubulin compartmentalization in 
the growth cones of Gpm6anull*Gpm6bnull cortical neurons. This mislocalization is found in all 
neurite tips; no matter if they belong to the axons or to the dendrites. It is important to recall 
that M6A as well as M6B are expressed in basically all cortical neurons and that both 
neuronal proteolipids are present in axons as well as in dendrites. It is the absence of the 
M6-proteins in the neurites that leads to modified growth cone morphology. Thereby the M6 
neuronal proteolipids are required for the normal segregation of cytoskeletal proteins at the 
growth cones.  
 
 
4.1.5. M6A and M6B are required for normal reaction to ephrinA5 
To assess if there is a functional response to the altered growth cone morphology and actin-
tubulin compartmentalization it was chosen to realize a “growth cone collapse assay”. For the 
assay ephrinA5, widely known to act as a collapse agent on neurons, was chosen (Knöll et 
al., 2006; Pandithage et al., 2008). The collapse or non-collapse was defined as the absence 
or presence, respectively, of a lamellipodium or veil-like structure in the growth cones of the 
axon or longest neurite. The experiment was performed on primary cortical neurons of E17 
mice embryos that were cultured for 2 DIV.  
 
On the representative images (Fig. 16) it can be observed that there is a difference in the 
responsiveness to ephrinA5 in the Gpm6anull*Gpm6bnull cortical neurons, in comparison to the 
wild-type, Gpm6anull and Gpm6bnull single-mutant cortical neurons. These dKO neurons do 
not react to the commonly used amount of ephrinA5 (1 µg/ml) (Knöll et al., 2006; Pandithage 








Figure 16. Responsiveness to ephrinA5 induced growth cone collapse assay. 
WT, Gpm6anull, Gpm6bnulland dKO cortical neurons from E17 mice were cultured and after 2 DIV a “growth 
cone collapse assay” with ephrinA5 was performed. Cells were then fixed and stained against Tuj1 (in green) 
and Phalloidin (in red). Examples for each given genotype with the control (recombinant Fc) and ephrinA5 
(recombinant ephrinA5/Fc chimera, 1 µg/ml or 2 µg/ml) treatment. The dKO cortical neurons do not react to 




The quantification of the “growth cone collapse assay” is given in table 4. There is a clear 
difference in the responsive behaviour of the dKO neurons as they don’t react to the growth 
cone collapse induction in the same manner than wild-type, Gpm6anull and Gpm6bnull single-






Table 4. Quantification of the growth cone collapse assay induced by ephrinA5. 
Growth cone collapse assay performed on 2 DIV cultured WT, Gpm6anull, Gpm6bnulland dKO cortical neurons 
from E17 mice. dKO cortical neurons react differently to the ephrinA5 induced collapse assay at 1 µg/ml (star). 
The axonal growth cone was categorized as non-collapsed (Non C) or collapsed (C) regarding the presence or 
absence of a lamellipodium. The percentage of collapsed (%C) growth cones is given. The experiment was 
performed on n = 3 per genotype.  
Control Ephrin A5 [1 µg/ml] Ephrin A5 [2 µg/ml] 
 
Non C C %C Non C C %C Non C C %C 
WT 34 41 55 15 62 81 9 67 88 
Gpm6anull 49 28 36 18 57 76 19 58 75 
Gpm6bnull 57 43 43 12 64 84 16 59 79 
dKO 53 23 30 38 38 50* 15 60 80 
 
 
A chi-square pair wise comparison of the distributions of the cortical neurons regarding their 
status of being collapsed or non-collapsed under the different conditions was performed 
(Table 5). When comparing the reaction between the control situation and the standard 
ephrinA5 dose (1 µg/ml) it is clear that there is a very highly significant difference in the wild-
type, Gpm6anull and Gpm6bnull null mutant cortical neurons. Most of their growth cones do 
react to the ephrinA5 collapse induction. The dKO neurons react, but to a much lesser 
extend to this collapse. Moreover there is no alteration when comparing the responsiveness 
between the two concentrations of ephrinA5 (1 µg/ml Vs 2 µg/ml) in the wild-type, Gpm6anull 
and Gpm6bnull single-null mutant cortical neurons. However there is a very highly significant 
difference in the Gpm6anull*Gpm6bnull cortical neurons. Most of the axonal growth cones 
require the higher ephrinA5 dose to respond with an extensive collapse reaction (50 % of 













Table 5. Chi-square comparison of the growth cone collapse assay induced by ephrinA5. 
Growth cone collapse assay performed on 2 DIV cultured WT, Gpm6anull, Gpm6bnulland dKO cortical neurons 
from E17 mice. Chi-square pair-wise comparison (n = 3 per genotype; each ≥ 25 neurons) of ephrinA5 
response at 1 µg/ml and 2 µg/ml. dKO neurons required a two-fold increased dose of ephrinA5 to achieve a 
response comparable to wild-type, Gpm6anull and Gpm6bnull cortical neurons. The P-value is shown and in 
parenthesis the Pearson Chi-Square statistic with the degrees of freedom as subscript.  
 Ctrl Vs EphrinA5 [1 µg/ml] EphrinA5 [1 µg/ml] Vs [2 µg/ml] 
WT 8.999 · 10-4 (11.6251) 0.267 (1.5991) 
Gpm6anull 8.592 · 10-7 (24.2151) 1.000 (0.0091) 
Gpm6bnull 4.220 · 10-8 (29.2841) 0.539 (0.4871) 
dKO 0.013 (6.7331) 1.542 · 10-4 (14.9141) 
 
The result of this experiment is summarized in the diagram bar of figure 17. There is a 
notable difference in the behaviour of the Gpm6anull*Gpm6bnull cortical neurons towards the 
growth cone inducing agent ephrinA5. These neurons require a much higher dose to achieve 
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Figure 17. Responsiveness to ephrinA5 induced growth cone collapse assay (diagram)  
WT, Gpm6anull, Gpm6bnulland dKO cortical neurons from E17 mice were cultured and after 2 DIV a “growth 
cone collapse assay” with ephrinA5 was performed and assessed on the axonal growth cone (n = 3). dKO-
neurons required a two-fold increased dose of ephrinA5 to achieve a response comparable to wild-type, 
Gpm6anull and Gpm6bnull cortical neurons. 
Examining the control group, there is a significant difference regarding the axonal growth 
cones. As the non-collapsed growth cone has been defined as the presence of a 
lamellipodium, one can observe that the dKO as well as the Gpm6anull cortical neurons have 
significantly more growth cones with lamellipodia than the wild-type or the Gpm6bnull cortical 







Table 6. Abundance of axonal growth cones with lamellipodia. 
WT, Gpm6anull, Gpm6bnulland dKO cortical neurons from E17 mice were cultured and after 2 DIV the presence 
or absence of a lamellipodium on the axonal growth cone (GC) was assessed. It is shown the percentage of 
axonal growth cones with a lamellipodium (GC + lamellipodium). dKO and Gpm6anull cortical neurons have 
more axonal growth cones with a lamellipodium than wild-type or Gpm6bnull cortical neurons. Chi-square pair 
wise comparison of the distribution of frequencies relative to wild-type neurons (n=3 animals per genotype; each 
≥ 25 neurons), shown the Pearson Χ2 statistic (Pearson Χ2), the degrees of freedom (df) and the P-value (P).
 GC + lamellipodium (%) Χ2 : WT Vs 
WT 45 Pearson Χ2 df P 
Gpm6anull 64 5.135 1 0.034 
Gpm6bnull 57 2.337 1 0.130 
dKO 70 9.880 1 0.003 
 
The difference between the Gpm6anull and the WT is significant (P = 0.0034) and it is highly 
significant between the Gpm6anull*Gpm6bnull cortical neurons and the wild-types (P = 0.003). 
There is no significant difference when comparing the other groups. This result demonstrates 
that in the absence of the neuronal proteolipid protein M6A (Gpm6anull and 
Gpm6anull*Gpm6bnull) the axonal growth cones of their cortical neurons show a significantly 
increased abundance in lamellipodia. And this effect is increased when the ortholog M6B is 
as well absent.  































Figure 18. Abundance of axonal growth cones with lamellipodia. 
WT, Gpm6anull, Gpm6bnulland dKO cortical neurons from E17 mice were cultured and after 2 DIV the presence 
or absence of a lamellipodium on the axonal growth cone was assessed. In comparison to wild-type or 
Gpm6bnull, Gpm6anull and dKO cortical neurons have significantly more (*) and highly significantly more (**) 




The increased number of neuronal growth cones regarding the presence of lamellipodia 
points once more to a role of M6 proteins in the normal morphology and function of neuronal 
growth cones.  
 
To further explain the observed altered behaviour of the Gpm6anull*Gpm6bnull cortical neurons 
regarding the ephrinA5 induced growth cone collapse assay, immunoblot analysis was 
performed on cortical neuron lysates at 2 DIV (from E17 embryos). It was tested whether 
ephexin-1 levels were altered. Ephexin-1 levels are in relationship with the abundance of Eph 
receptors (see section 2.1.2., reviewed by Egea & Klein, 2007). This simplified the approach 
to test if the abundance of Eph-receptors were altered, as ephrinA5 binds to EphA1-8 as well 
as EphB2 (reviewed by Pasquale, 2004).  
 
As can be observed on figure 19, the preliminary result of the immunoblot performed on the 
lysates of wild-type and Gpm6anull*Gpm6bnull cortical neurons show a decreased abundance 
of ephexin1 in the Gpm6anull*Gpm6bnull cortical neurons. This would argue for a decreased 
overall level of Eph-receptors in the dKO neurons, a likely explanation why these dKO 
neurons have an impaired response to the ephrinA5 induced growth cone collapse.  
 
Another downstream event to investigate was the levels of RhoA. RhoA is the key signalling 
molecule when referring to growth cone collapse (Wahl et al., 2000; reviewed in Hall & Lalli, 
2010). Upon its activation, it leads to collapse of the actin filaments. In the dKO cortical 
neuron lysates, the abundance of RhoA is slightly decreased. The lower levels would argue 
for less total cellular RhoA, regardless of its activation status. A lower abundance of RhoA 







Figure 19. Immunoblot of cortical neuron lysates.
WT and Gpm6anull*Gpm6bnull cortical neurons from E17 mice were cultured and lysed after 2 DIV (n = 2 - 3).  
A) Immunoblot showing the levels of ephexin-1 and actin as a loading control. It seems that in the dKO cortical 
neuron lysates the abundance levels of ephexin1 are decreased. 
B) Immunoblot against total RhoA with tubulin as a loading control. The RhoA abundance levels seem to be 




The immunoblot demonstrates the importance of neuronal M6 proteolipid proteins in the 
proper function of the growth cone and its associated cytoskeleton proteins as well as the 
appropriate abundance (and possibly localization) of signalling receptors including Ephs.  
 
 
4.1.6. Impaired neurite outgrowth in the absence of M6 proteins 
Previous results have shown that upon application of the monoclonal M6 antibody against 
M6A there was a reduced neurite outgrowth of cultured cerebellar wild-type neurons 
(Lagenauer et al., 1992).  
 
To test if a similar effect exists in the chronic absence of this protein, as well as of the 
homologue M6B, primary cortical neurons of E15 mice were cultured for 3 DIV to assess 
their neurite length. This experiment was performed on wild-type, Gpm6anull, Gpm6bnull and 
Gpm6anull*Gpm6bnull cortical neurons (Fig. 20, with 4 individuals per genotype and three 








Figure 20. Impaired neurite outgrowth of M6 mutant cortical neurons. 
WT, Gpm6anull, Gpm6bnulland dKO cortical neurons from E15 mice were cultured and after 3 DIV  the neurites 
were immunostained with the antibody Tuj1. Representative examples for each genotype. Scale bar = 25µm.  
 
The resulting data (Table 7) show a decreased neurite length in the cortical neurons lacking 
M6. A two-sided T-test was performed, and the resulting P-values demonstrate a very highly 
significant and decreased neurite length of the Gpm6anull, the Gpm6bnull and the 
Gpm6anull*Gpm6bnull cortical neurons in comparison to the wild-types. Gpm6anull and 
Gpm6anull*Gpm6bnull neurites are also significantly shorter than those of Gpm6bnull cortical 
neurons. This shows that the Gpm6bnull cortical neurons are affected in their neurite 









Table 7. Impaired neurite outgrowth of M6 mutant cortical neurons. 
WT, Gpm6anull, Gpm6bnulland dKO cortical neurons from E15 mice were cultured and after 3 DIV the neurite 
length was measured according to the Tuj1 immunocytochemistry. It is exhibited the mean neurite length 
(Neurite length, in µm) and the P-value for the two-sided T-test for the different comparisons. The neurites of 
Gpm6anull, Gpm6bnulland dKO cortical neurons are shorter than those of the wild-type. Additionally the neurites 
of the Gpm6anull and dKO cortical neurons have a decreased length in comparison to the Gpm6bnull cortical 
neurons (n = 4, 3 technical replicates each, 163 - 183 cells were quantified per genotype). Shown T statistic with 
the degrees of freedom as subscript, and the P-value. 






WT 235.253    
Gpm6anull 102.265 15.375240, 1.337 · 10-37   
Gpm6bnull 138.367 10.010309, 1.287 · 10-20 -5.162317, 4.330 · 10-7  
dKO 98.534 15.989232, 2.756 · 10-39 0.701359, 0.484 5.796305, 1.689 · 10-8 
 
Figure 21 shows a bar diagram of the mean neurite length of the four genotypes and the 
resulting significance levels according to the T-test. Categorizing the neurons regarding their 
neurite length allows a chi-square pair-wise comparison of all the distributions (Table 8) and 
this reveals a significantly different frequency distribution of the neurite length of any 






Table 8. Impaired neurite outgrowth of M6 mutant cortical neurons. 
WT, Gpm6anull, Gpm6bnulland dKO cortical neurons from E15 mice were cultured and after 3 DIV the neurite 
length was measured according to the Tuj1 immunocytochemistry. It is represented the P-value for the chi-
square test and in parenthesis the Pearson Χ2 statistic and the degrees of freedom as subscript. There is a 
significant difference in the frequency distribution of the neurite length of every genotype towards every other.  
 WT Gpm6anull Gpm6bnull 
Gpm6anull 5.919 · 10-30 (157.2818)   
Gpm6bnull 1.161 · 10-14 (83.0988) 4.960 · 10-5 (31.5327)  
dKO 2.816 · 10-33 (173.1528) 0.025 (12.7875) 1.159 · 10-6 (40.1887) 
 
The following diagrams show the mean neurite length for each genotype and the resulting 
significance levels after the T-test (Fig. 21A) and the categorized distribution of the cortical 







Figure 21. Impaired neurite outgrowth in M6 deficient cortical neurons.
A. Total neurite length analysis (mean ± SEM), showing a reduced neurite length as indicated (*** = P<0.001, 
T-test). n = 4 animals; 3 technical replicates per genotype.  
B. Neurite length distribution in the four genotypes. X2 pair-wise comparison determined a significantly 
different distribution of the neurite length between all genotypes (P<0.05). 
 
The reduced neurite outgrowth displays the requirement of the neuronal M6 proteolipid 
proteins in this process. The absence of M6B already induces a very significant decrease in 
the neurite length. However, the lack of M6A has even more drastic consequences. Thus, 
this evidence suggests that M6 proteins have an important role in the normal neuronal 







4.1.7. Neurite outgrowth and cholesterol 
As demonstrated above, neurons that lack M6 proteins do have impaired neurite outgrowth. 
It has been proven before that the oligodendroglial proteolipid protein PLP, ortholog to M6A 
and M6B, binds directly to cholesterol (Simons et al., 2000; Krämer-Albers et al., 2006). And 
this has also been shown for M6B (Werner H., pers. comm.).  
 
Cholesterol is essential for the proper neuron function, like e.g. for the maintenance of the 
plasma membrane itself, for locating ion channels and signalling proteins into lipid rafts, and 
for the functionality of the synaptic machinery (reviewed in Benarroch, 2008). To assess if 
there is a relationship between the neuronal proteolipids in their function related to neurite 
outgrowth and cholesterol, primary cortical neurons were cultured under different 
concentrations of cholesterol. Wild-type and Gpm6anull*Gpm6bnull cortical neurons of E15 
mice were cultured for 3 DIV. The experiment was performed with four embryos per 
genotype and three technical replicates per condition, resulting in 38 - 36 neurons evaluated 
per animal. The applied cholesterol concentrations were: 0 µg/µl, 0.1 µg/µl and 1 µg/µl of 
cholesterol and the neurite length was measured.  
 
As depicted in table 9, wild-type cortical neurons show a clear decrease in their neurite 
outgrowth length once the cholesterol concentration is above 0.1 µg/µl, and this decrease 
augments with an increasing dose (1 µg/µl). This is in congruence with prior results (Ko et al., 
2005) and also shows how critical cholesterol amounts are for proper neuronal function.  
It was surprising to observe that the dKO cortical neurons do not react to the modified 
cholesterol concentrations. They do have a significant reduction in their neurite length per se 
(as proven before), but this stays unaltered and at the same magnitude, no matter the 
different concentrations of cholesterol. Nonetheless, wild-type neurons have significantly 

















Table 9. Neurite outgrowth in cortical neurons upon cholesterol application. 
E15 mice cortical neurons were cultured for 3 DIV under different cholesterol concentrations and were stained 
with Tuj1. The neurite outgrowth was measured.  
A) Mean neurite length of WT and dKO cortical neurons under the different cholesterol concentrations.  
b) Statistical outcome of a T student test, showing the T statistic with the degrees of freedom as subscript, and 
the P-value. 
Mean neurite length (µm) 
 WT dKO 
0 µg/ml 146.817 77.331
0.1 µg/ml 136.822 86.685





Vs Genotype Vs Cholesterol concentration 
 WT Vs dKO  WT dKo 
0 µg/ml 7.930318, 3.746 · 10-14 0 µg/ml Vs 0.1 µg/ml 1.061346, 0.289 -1.319357, 0.188
0.1 µg/ml 6.358342, 6.548 · 10-10 0 µg/ml Vs 1 µg/ml 3.694340, 2.573 · 10-4 -0.932354, 0.352
1 µg/ml 3.654344, 2.989 · 10-4 0.1 µg/ml Vs 1 µg/ml 2.868351, 4.387 · 10-3 0.368354, 0.713 
 
 
The figure 22 exposes this clear effect: the neurite length of wild-type cortical neurons 
decreases upon increasing the cholesterol concentrations, and the dKO cortical neurons 
behave unaltered, preserving their anyway significantly reduced neurite length.  
 
This result demonstrates that neuronal M6 proteins interact directly or indirectly with 
cholesterol and this relates to their involvement in neurite outgrowth. The lack of M6 proteins 
makes cortical neurons not respond in the normal manner, which would mean a reduction in 











Figure 22. Neurite outgrowth of cortical neurons upon cholesterol application. 
E15 mice cortical neurons were cultured for 3 DIV under different cholesterol concentrations and were 
immunostained with Tuj1. The neurite outgrowth was measured. 
A) Representative images of WT and Gpm6anull*Gpm6bnull (dKO) cortical neurons under the different cholesterol 
concentrations. Scale bars = 20 µm.  
B) Bar diagram representing the mean neurite length (with the SEM) of WT and dKO neurons in the different 
cholesterol concentration.  
 
 
4.1.8. Growth cone morphology, adhesiveness and motility 
An essential evaluation was to prove how the cortical neurons that lack M6 proteins do 
behave while being in culture, as the prior results demonstrated an altered behaviour of the 
neurons in their neurite outgrowth and in their growth cone function. Therefore, primary 
cortical neurons of E17 wild-type and Gpm6anull*Gpm6bnull mice were subjected to in vivo 
imaging after being cultured 2 DIV. The microscopy was performed on a confocal setup and 
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reflection microscopy was used. As M6 proteins seem to be especially important in the 
growth cone, the analysis focused on this structure. The individual growth cones were 
imaged during ten minutes and an image was acquired every three seconds, so that for 
every growth cones were 201 frames which were converted into a video (Fig. 23A). From the 
wild-type cortical neurons nine growth cones were imaged, and ten in the 
Gpm6anull*Gpm6bnull ones. The imaging acquisition was chosen to be of a period of ten 
minutes, as it had already been assessed that the Gpm6anull*Gpm6bnull cortical neurons have 
an impaired neurite extension, so that there would be no masking of the effect of the reduced 






Figure 23. Morphometry of in vivo imaged cortical neuron growth cones. 
A) Cortical neurons of E17 WT and Gpm6anull*Gpm6bnull (dKO) mice were cultured for 2 DIV. In vivo imaging of 
their growth cones during 10 min, performing one image every 3 seconds. Depicted is the first image for one 
growth cone of each genotype. Scale bars = 5 µm. 
B) Representation of the normalized mean ratio of the perimeter against the total area. No significant 
differences could be observed.  
C) Representation of the normalized mean total area. No significant differences could be observed.  
 
The first approach was to analyse the morphometrical properties. The perimeter of each 
growth cone in each frame was determined, as well as the total surface. When comparing 
the normalized values for the ratio of the perimeter against the total area (Fig. 23B), as well 
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as the total area per se (Fig. 23C), no difference could be assessed. This was proven by 
realizing an ANOVA with repeated measurements (Greenhouse-Geisser) (perimeter / total 
area: F = 1.287, P = 0.287; total area: F = 0.411, P = 0.758). Thus, growth cones of cortical 
neurons that lack M6 proteins do have the same morphometrical properties than wild-type 
ones.  
 
Because of employing reflection microscopy, the various levels of attachment to the glass 
slide could be differentiated. Thereby, the following analysis was based on the different 
adhesion levels. The area of the growth cones was divided into “adhesive” and “non 
adhesive” according to the intensity levels on each single image (Fig. 24A). When performing 
the ratio of the normalized data of the “adhesion area” Vs the “non adhesion area” no 
differences could be proven (Fig. 24B, C). This was confirmed by means of an ANOVA with 
repeated measurements (Greenhouse-Geisser) (adhesion area / total area: F = 1.150, P = 
0.340). Consequently, the adhesive properties are also not altered when analysing neuronal 











Figure 24. Adhesiveness of in vivo imaged cortical neuron growth cones (cont.).
A) Cortical neurons of E17 wild-type and Gpm6anull*Gpm6bnull (dKO) mice were cultured for 2 DIV. The growth 
cones were imaged in vivo during 10 min, achieving one image every 3 seconds. According to the intensity 
levels, the growth cone area was classified into “adhesion” (red) and “non adhesion” (green) areas. Depicted are 
four example images of each genotype, chosen every second frame from the first one on. The time passed is 
indicated on each image. Scale bars = 5 µm. 
B) Representation of the normalized ratio of the adhesive area against the total area. No significant differences 
could be observed.  
C) Representation of the normalized mean adhesive area against the total area. No significant differences could 
be observed.  
 
Furthermore, the examination of the videos was performed in such a manner that the motility 
of the growth cones could be investigated, as this is an essential factor of the growth cone 
functionality. Between each frame of each single video, the differences form one to the next 
frame were analysed in such a way that the extension and retraction areas could be 
assessed (See Fig. 7). As the areas occupied by the growth cone in one frame were 
subtracted form the prior one, extension was evaluated as values minor than zero and 
retraction as values larger than zero. If there would be no difference, the sum would be zero. 
When comparing the growth cones regarding the extension (Fig. 25A-B) and retraction (Fig. 
25C-D) levels no differences could be observed between wild-type and Gpm6anull*Gpm6bnull. 
This is obvious when observing the normalized mean alteration of the sum of the retraction 
and extension values (Fig. 25E), as it is basically identical for the growth cones of wild-type 
and Gpm6anull*Gpm6bnull cortical neurons. Additionally, when plotting the normalized 
differences of retraction and extension (Fig. 25F) no differences could be observed. An 
ANOVA with repeated measurements (Greenhouse-Geisser) was performed and validated 
this (retraction + extension:  = 0.992, P = 0.494; retraction-extension: F = 1.184, P = 0.286). 
Yet again, there is no difference of the in vivo behaviour of the Gpm6anull*Gpm6bnull cortical 












Figure 25. Motility of in vivo imaged cortical neuron growth cones. 
Cortical neurons of E17 WT and Gpm6anull*Gpm6bnull (dKO) mice were cultured for 2 DIV. Growth cones were 
image in vivo during 10 min, performing one image every 3 seconds. The differences in area occupied by the 
growth cone were assessed between each frame of each single video, by subtracting the occupied area of one 
frame with the prior one. Thereby positive values measure retraction and negative values measure extension. If 
there is no net movement, the value would be zero.  
A-B) Representation of the normalized extension values for WT (A) and dKO (B) growth cones.  
C-D) Representation of the normalized retraction values for WT (A) and dKO (B) growth cones.  
E) Representation of the normalized mean sum of the retraction and extension values in WT (black) and dKO 
(red) growth cones.  




This in vivo analysis demonstrates that the short-term morphometry, adhesion and motility is 






4.1.9. Cortical development and corpus callosum width 
The corpus callosum is the largest commissure of the brain that connects most cortical areas 
of each cerebral hemisphere (Kandel et al., 2000). It was chosen for studying the possible in 
vivo consequences of the effect of the impaired neurite outgrowth and altered growth cone 
function proven before in cortical neurons that lack chronically neuronal M6 proteins.  
Therefore, brains of P5 wild-type (n = 4) and Gpm6anull*Gpm6bnull (n = 5) mice were fixed and 
coronal sections were stained with HE and the width of the corpus callosum was measured. 
The examination was divided into two regions in the caudorostral axis: sections comprising 
the corpus callosum anterior to the hippocampus or sections including the corpus callosum 






Figure 26. Reduced corpus callosum width at P5 in Gpm6anull*Gpm6bnull mice.
P5 brain sections of wild-type (WT) and Gpm6anull*Gpm6bnull (dKO) mice were stained with HE and the corpus 
callosum width was measured. It was differentiated between sections anterior to the hippocampus (Anterior to Hc) 
or comprising the hippocampus (With Hc). 
A) Representative images of the corpus callosum for each genotype and each section level. Scale bar = 100 µm. 
B) Bar diagram representing the mean corpus callosum width. The SEM is shown, as well as the levels of 
significance differences (*, P<0.05; ***P>0.001) according to a student T-test. 
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The comparison between the two genotypes by means of a students T-test revealed a 
significant difference (Table 10), owing to a decreased corpus callosum width in the 
Gpm6anull*Gpm6bnull mice. This occurred in both analyzed section levels and the differences 







Table 10. Decreased corpus callosum width at P5 in Gpm6anull*Gpm6bnull mice.
P5 brain of wild-type (n = 4) and Gpm6anull*Gpm6bnull (n = 5) mice were fixed, sectioned and stained with HE. 
The corpus callosum width was assessed in regions anterior to the hippocampus (Anterior to Hc) or in regions 
comprising the corpus callosum and the hippocampus (With Hc). Depicted is the mean corpus callosum width in 
µm, in parenthesis the number of counts per genotype and the T-statistic with the degrees of freedom as 
subscript, and the P-value.




Anterior to Hc 116.300 (18) 102.727 (34) 2.28540, 0.028 
With Hc 143.405 (15) 121.776 (21) 4.16734, 2.002· 10-4 
 
This proves that neurons lacking neuronal M6 proteolipid proteins provoke a deficient 
formation of the major white matter tract in the brain. According to prior experiments this 
developmental defect in neuronal projections seems to be compensated at P30 (Fünfschilling 
U., Werner H., pers. comm.), but further investigations will assess this into more detail.  
Neuronal M6 proteolipid proteins are required for an efficient and normal development of 
axonal tracts in the white matter, as is the corpus callosum. 
 
 
4.2. Tetraspanin2 in CNS myelination 
 
 
4.2.1. Tetraspanin2 expression in myelin 
As a first step to study the function of TSPAN2 in the CNS myelin, P75 old wild-type and 
PLPnull mice were perfused, their brains sectioned and immunostained using an antibody 
against TSPAN2 (Birling et al., 1999). In wild-type brain sections the TSPAN2 antibody stains 
profusely white matter regions, containing myelin, like e.g. the corpus callosum or the 
striatum (Fig. 27). But on PLPnull mice sections, the TSPAN2 labelling reveals a much higher 
TSPAN2 abundance. This effect is found throughout the white matter tracts of the brain. 
Hence, it is in agreement with prior results obtained in immunoblots of CNS myelin-enriched 
fractions (Werner H., pers. comm.). This suggests that TSPAN2 could compensate for the 
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Figure 27. Tspan2 staining in the striatum of WT and PLPnull mice. 
P75 brain sections of the striatum of WT and PLPnull mice were immunostained using a TSPAN2 antibody.  
A) PLPnull mice have a higher abundance of TSPAN2 labelling. Scale bar = 50 µm. 
B) Magnification of A, demonstrating that the increased TSPAN2 labelling in PLPnull mice is due to the more 
profound staining of the white matter bundles, as well as of the OL of the surrounding gray matter (arrow). 
Scale bar = 25 µm. 
 
4.2.2. Targeted inactivation of the murine Tspan2 gene  
The early onset of the nervous system specific expression of TSPAN2 (Nielsen et al., 2006; 
Dugas et al., 2006), its distribution in CNS myelin (Birling et al., 1999), as well as its high 
abundance in PLPnull myelin suggests that TSPAN2 is an important protein for CNS 
myelination and maintenance. To elucidate the function of TSPAN2 in vivo, the generation of 
conventional TSPAN2null mice was pursued.  
 
Briefly, to generate TSPAN2null mice, the Tspan2 gene had to be modified by homologous 
recombination of a Tspan2 gene-comprising targeting vector in embryonic stem (ES) cells in 
vitro. ES cells that are positively targeted are microinjected into host blastocysts, and foster 
mothers will give rise to ES cell-chimeric mice. These chimeric mice can be distinguished by 
their spotted fur colour. When breeding chimeras with wild-type mice and with successful 
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germline transmission, the offspring will be heterozygous for the Tspan2 gene (represented 







Figure 28. Generation of a C57BL/6 null-mutant mouse by gene targeting
The gene of interest is targeted by homologous recombination (star) in ES cells and these are injected into host 
blastocysts to produce ES cell–mouse chimeras. When using ES cells derived form C57 black B6 mice and 
injecting into host blastocysts derived form C57BL/6J-Tyrc-2J albino mice, the chimeric offspring will be black-
white patched. After breeding these chimeras with albino-C57 mice, the offspring after the germline transmission 
(F1 generation) will be black, representing the fur colour of the original ES cell (Taken from Seong et al., 2004).  
 
The targeting vector comprised three distinct regions (generated by de Monasterio Schrader 
P., Werner H. & others): (1) a 5’ “short arm”, homologous to part of the 5’ UTR of the Tspan2 
gene as a template, flanked by XhoI/NotI restriction sites, (2) a neomycin resistance cassette 
flanked by two FRT sites, which gives upon its integration resistance to the neomycin-
analogue G418 (essential for the ES cell positive-selection), and (3) a 3’ “long arm” 
homologous to a sequence in intron 1 of the Tspan2 gene, flanked by SbfI/Sac2 restriction 
sites. The vector backbone was the pCom-True (kindly provided by Schwab M.). The 
targeting vector proper sequence was verified by PCR and sequencing (data not shown). 
The gene targeting vector replaced most of the 5’ UTR, the first coding exon, exon 1, and a 
large fragment of intron 1. This would, after homologous recombination, impede the Tspan2 
transcription, thereby giving rise to mice lacking TSPAN2.  










Figure 29. Targeting strategy to inactivate the murine Tspan2 gene.
Genomic locus showing the 5’ UTR (gray box) and the two exons (black box). The pCom-True-Tspan2null 
targeting vector will excise at the 5’ side part of the 5’ UTR, and the first coding exon 1 (exon 1), and at the 3’ it 
will target the large intron 1. Therefore, the Tspan2null recombined allele will have a short initial segment of the 
5’ UTR followed by the neomycin resistance cassette. This will lead to no Tspan2 transcripts. On the 
TSPAN2null recombined allele are depicted primer locations that lead to identify homologous recombined ES 
cells (arrows). The PCR results for these are given in Fig. 30. 
For the gene targeting, ES cells derived form C57BL/6 mice were used. This was a relative 
novel technique, as until recently most ES cells used for homologous recombination were 
derived form SV-129 mice. But the usage of C57BL/6-derived ES cells has several 
advantages. On one hand it is the reference strain for the mouse genome and thereby all 
further genetic investigations are facilitated. As well the C57BL/6 strain is the reference strain 
used in most biological investigations. And by using C57BL/6-derived ES cells, no 
backcrossing is necessary after germline transmission, which saves months of breeding, but 
also close to the insertion sites of the target vector there will be no different remaining 
sequences from the original ES cell strain (reviewed by Seong et al., 2004). Therefore, 
C57BL/6-derived ES cells were chosen for the Tspan2 gene inactivation.   
 
Before the electroporation of the C57BL/6-derived ES cells, the targeted vector was 
linearized with ClaI. Nested PCR screening was performed to detect the ES cell clones 
containing the correct genomic target insertion. The “positive” clone (clone #5.3; 1 out of 48), 
where the gene targeted vector was inserted properly at the 5’ and 3’ ends of the Tspan2 
gene (Fig. 30A), was injected into C57BL/6J-Tyrc-2J albino derived blastocysts, which were 
carried out by foster mothers, and gave rise to chimeric offspring (Fig. 30B). By breeding the 
33 resulting chimeras with C57BL/6 mice, germline transmission was achieved in two cases 
(mice #580, #590; 2 out of 352, Fig. 30C) in the F1 generation. These mice were 
heterozygous for the Tspan2 gene (Fig. 31) and were bred to each other, to give rise to 








Figure 30. Homologous recombination and germline transmission after Tspan2 gene targeting. 
A) PCR result of the ES clone #5.3 that showed a homologous recombination in the 5’ end (5’PCR) and in the 
3’ end (3’PCR), the primer pairs are depicted in figure 29, a control vector was used as a positive control.  
B) Chimeric animals resulting from the injection of the homologous targeted clone #5.3 into C57BL/6J-Tyrc-2J 
albino derived blastocysts. Note the black-white patched colour, representing the mosaic genetic properties of 
the mouse. 
C) PCR results demonstrating the germline transmission in the F1 generation. The top two PCR results verify 
the 5’ recombination, the lower one proves the 3’ recombination. PCR performed on genomic DNA of the F1 
offspring #580 and #590. 
 
 
As could already be observed from the F2, and confirmed by the posterior breeding 
behaviour, the TSPAN2null mice are good breeders and give rise to offspring with genotypes 








Figure 31. Germline transmission and first TSPAN2null mouse.
A) Genotyping PCR on genomic DNA of the F1 and F2 generation, demonstrated the two heterozygous mice 
for the recombined Tspan2 allele of the F1 (#580, #590) and their offspring, the F2. In the F2 appeared mice 
being homozygous for the wild-type allele (#751), heterozygous for the recombined allele (#750, #752, #753), 
and homozygous for the recombined allele (#754, star). This was the first complete TSPAN2null mouse.  
B) An image of the first TSPAN2null mouse (#764, star on the PCR). 
 
 
4.2.3. Characterization of TSPAN2null mice 
The TSPAN2null mice breed normally, and have no obvious phenotypic abnormalities at least 
in the first 10 month of age. The fact that there is no obvious phenotype could probably be 
explained by some compensatory mechanism of other myelin tetraspanins.  
 
To assess the absence of TSPAN2 protein in the TSPAN2null mice, immunoblot of CNS-
myelin enriched fractions was performed on P75 mice. The analysis included wild-type, 
TSPAN+/-, TSPAN2null and PLPnull mice. The TSPAN2 immunoblot revealed a clear band in 
the wild-type mice and, indeed, revealed no band in the TSPAN2null mice (Fig. 32). This 
demonstrates that the TSPAN2null mice do actually lack the TSPAN2 protein. There is a 
strong decrease in the intensity of the TSPAN2 band of the TSPAN+/- mice, proving that the 
heterozygous mice do actually have reduced levels of TSPAN2. Confirming prior results, the 
levels of TSPAN2 were prominently increased in the PLPnull mice. CNP was used as a 
loading control, as no differences could be observed in the levels of the non-compact myelin 
protein CNP in these genotypes.  
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The immunoblot against PLP/DM20 demonstrated the expected absence in the PLPnull mice 
and similar levels in the wild-type and TSPAN2null mice. It seemed that in the TSPAN+/- mice 
the levels of PLP/DM20 are reduced. CNP was used as a loading control and showed no 
differences. Surprisingly, there is an increase in the levels of MBP in the TSPAN2null mice. 
MBP is the second most abundant protein in compact CNS myelin (after PLP) and acts on 
compaction, as its positive charges attract the polar cytoplasmic membrane lipids, thereby 
putting the two membrane bilayers in close apposition (reviewed in Boggs, 2006). This 
increase in MBP could be a compensatory effect for a potential less compacted myelin in 
TSPAN2null mice. Further investigations will be needed to study the possible interaction of 








Figure 32. Characterization of TSPAN2null mice.
Immunoblot analysis was performed on P75 CNS-myelin enriched fraction of wild-type (WT), TSPAN+/-, 
TSPAN2null and PLPnull mice (n = 2). TSPAN2 was absent in the TSPAN2null mice, very decreased in the 
TSPAN+/- mice and highly increased in PLPnull mice, when comparing to WT. There was no positive signal of 
PLP/DM20 in the PLPnull mice (as expected) and the levels seemed to be reduced in the TSPAN+/- mice, when 
comparing to WT and TSPAN2null mice. Interestingly, the MBP levels were increased in the TSPAN2null mice. 







4.2.4. Weight increase in TSPAN2null mice 
As TSPAN2 has been observed to be increased in PLPnull mice, the TSPAN2null*PLPnull mice 
were generated by cross-breeding the single-mutants, for permitting the in vivo study of the 
chronic absence of this two CNS myelin tetraspan proteins. These TSPAN2null*PLPnull mice 
do breed normally and have no obvious phenotypes, at least until 10 month of age.  
 
The weight increase was measured in wild-type, TSPAN2null, PLPnull and TSPAN2null*PLPnull 
mice, for assessing if the normal body weight increase during development was achieved. 
The weight was measured every second day between P2 and P30 (n = 16 - 23) in the four 
genotypes. An ANOVA with repeated measurements was performed and it demonstrated a 
significant effect of the genotypes on the weight increase. The post-hoc Bonferroni correction 
demonstrated that the weight increase in wild-type and TSPAN2null mice behaves equally, as 
well as in the PLPnull and TSPAN2null*PLPnull mice (Table 11). The latter two genotypes had 





Table 11. Reduced weight increase in PLPnull and TSPAN2null*PLPnull mice.
The weight increase was measured in wild-type (WT), TSPAN2null, PLPnull and TSPAN2null*PLPnull mice every 
second day between P2 and P30 (n = 16 – 23). The post-hoc Bonferroni correction (given the P-values) 
demonstrated that the weight increase is similar in (WT), TSPAN2null mice, while it is reduced in PLPnull and 
TSPAN2null*PLPnull mice, being equal between them. 
 WT TSPAN2null PLPnull 
TSPAN2null P = 0.230    
PLPnull P = 5.369 · 10-11 P = 7.918 · 10-7  
TSPAN2null*PLPnull P = 3.934 · 10-10 P = 1.192 · 10-5 P = 1.000 
 
 
The diagram in figure 33A, shows the weight increase above mentioned.  
 
The weight differences were also analysed statistically at P30 (Fig. 33B), and an ANOVA 
analysis proved a significant differences between the wild-type and the PLPnull and 
TSPAN2null*PLPnull mice (with higher weights in wild-type mice), and between TSPAN2null and 
PLPnull mice, with a reduced weight in PLPnull mice. This reveals, as in the P2 to P30 
evaluation, a similar weight in wild-type and TSPAN2null mice, and a reduced one in PLPnull 
and TSPAN2null*PLPnull mice.  
 
The weight was also assessed at ten month of age in these four genotypes (n = 6 - 13) and 
yet again wild-type and TSPAN2null mice show the same weight (Fig. 33C), while the PLPnull 








Figure 33. Weight increase in wild-type, TSPAN2null, PLPnull and TSPAN2null*PLPnull mice. 
A) The weight increase was assessed every second day between P2 and P30. Wild-type (WT) and TSPAN2null 
mice showed similar weights, while PLPnull and TSPAN2null*PLPnull mice had a significant reduction.  
B) Diagram bar representing the weight at P30 (mean ± StDev). The table below depicts the result of the 
Bonferroni Post-hoc (P-value).  
C) Diagram bar representing the weight at 10 months of age (mean ± StDev). The table below depicts the 
result of the Bonferroni Post-hoc (P-value). 
 
 
Therefore, regarding their weight increase during early postnatal development and in 
adulthood, wild-type and TSPAN2null mice behaved in the same manner, while PLPnull and 
TSPAN2null*PLPnull mice showed reduced weights at the different time points evaluated.  
 
 
4.2.5. Protein composition in TSPAN2null mice 
To evaluate if the protein composition in CNS myelin was altered in the absence of TSPAN2, 
silver stainings were performed with CNS-myelin enriched fractions. At P30, no obvious 
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differences could be observed in the TSPAN2null mice (Fig. 34A), but in PLPnull and 
TSPAN2null*PLPnull mice the expected and prominent bands of PLP/DM20 (20 - 23 kDa) were 
absent. This was equivalent when performing the analysis at P75. Thus, in the absence of 







Figure 34. Silver staining of TSPAN2null CNS myelin.
A CNS-myelin enriched fraction was analyzed by means of silver staining (n = 2). 
A) Analysis at P30 including wild-type (WT), TSPAN2null, PLPnull and TSPAN2null*PLPnull (dKO) CNS-myelin 
enriched fractions. PLP/DM20 is absent in the PLP-null mutations (as expected), no other major differences 
could be observed.  
B) Analysis at P75 including WT, TSPAN2+/-, TSPAN2null and PLPnull of CNS-myelin enriched fractions. No 
obvious differences could be observed, apart form the lack of PLP/DM20 in PLPnull mice.  
 
 
As, on the broad assessment level that a silvergel allows, no differences had been observed, 
the further evaluations were performed with immunoblots.  
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Therefore, immunoblots of CNS-enriched myelin fractions were performed on P30 wild-type, 
TSPAN2null, PLPnull and TSPAN2null*PLPnull mice (Fig. 35). The closely related to TSPAN2, 
tetraspanins CD9 and CD81 were assessed (See 2.3.1.). The paranodal protein CD9 
revealed no abundance differences in the four genotypes. But CD81 showed an increased 
abundance in TSPAN2null, PLPnull and TSPAN2null*PLPnull, and especially its smaller isoform 
was more abundant in PLPnull and TSPAN2null*PLPnull mice. CD81 seems to compensate for 
the absence of TSPAN2 and PLP. As suggested in the immunoblot of P75 CNS-myelin 
fractions (Fig. 32), the abundance of MBP was also increased at P30. The two smaller 
isoforms were more abundant in the TSPAN2null, PLPnull, and TSPAN2null*PLPnull mice, and 
the larger isoform in the two latter genotypes. Again, this increase in the MBP levels could 
argue for a manner of compensating for reduced CNS myelin compaction. On the other side, 
two other myelin tetraspanins, CD82 and CD63 showed no alterations, as well as the non-
compact myelin protein CNP.  
Fyn was tested, as tetraspanins are integrators and assemblers of signalling molecules, and 
the tyrosine kinase Fyn is known to be a key downstream signalling element in OLs 
maturation (reviewed in Krämer-Albers & White, 2011). Thus, TSPAN2 could be involved in 
the assembly of this kinase. However, the immunoblot did not reveal any differences when 












Figure 35. Immunoblot analysis of TSPAN2null mice.
Immunoblots were performed on CNS-myelin enriched fraction at P30 (n = 3) of wild-type (WT), TSPAN2null, 
PLPnull and TSPAN2null*PLPnull (dKO) mice. The tetraspanin CD9 showed no difference. The smaller isoform 
of the tetraspanin CD81 was more abundant in TSPAN2null, PLPnull and dKO mice. MBP showed an 
increased abundance in TSPAN2null, PLPnull and dKO mice, as already proven in P75 CNS myelin (Fig. 32), 
and its larger isoform was even more abundant in PLPnull and dKO mice. Probably, MBP compensates for a 
reduced myelin compaction. The other tested tetraspanins, CD82 and CD63, showed no differences, as well 
as the non-compact myelin protein CNP and the tyrosine kinase Fyn. 
 
Thus, the prominent signalling protein in OLs, Fyn, is not altered. Additional examinations of 
different tetraspanin-associated signalling proteins in OLs should be pursued. But the 
consistent (at P30 and P75) increased abundance of MBP does suggest that the myelin 
sheaths lacking TSPAN2 need an extra-compaction to be properly functional. This is also 
apparent, as in the PLPnull (known to have a myelin compaction deficiency; Klugmann et al., 
1997) and TSPAN2null*PLPnull mice the larger MBP isoform is additionally increased. The 
possible compaction deficit should be further assessed, as well as the role of MBP in 
TSPAN2null mice. Furthermore, it seems that CD81 is the tetraspanin that compensated for 
the chronic lack of TSPAN2. The role of CD81 in TSPAN2null mice ought to be evaluated in 









5.1. Neuronal M6A and M6B proteolipids are abundant in cortical neurons  
The neuronal proteolipids M6A and M6B were known to be highly expressed throughout the 
neurons in the brain (Baumrind et al., 1992; Yan et al., 1996; Huminiecki et al., 2003), but it 
had to be proven that this was also the case in primary cortical neurons, the chosen ex vivo 
culture system. To define their exact localization, I immunostained primary cortical neurons 
with antibodies against M6A and M6B.  
 
Indeed, most neurons do express both proteolipids, but at different expression levels. On the 
whole, neurons express both M6 proteins in an equivalent manner, and some express 
majorly M6A or M6B. In the case of the predominant M6B expression, two types of neurons 
could be differentiated: some with a broad cellular expression and others with a more plasma 
membrane restricted expression. It could also be verified that M6A as well as M6B are 
evenly distributed on axons and dendrites. Hence, this demonstrated that the chosen ex vivo 
culture system is optimal for studying the role of neuronal proteolipids in the neuronal 
development.  
 
To reveal the precise localization of the neuronal proteolipids in the different neuronal 
domains, I performed co-localization studies. M6A or M6B were co-labelled with tubulin, a 
marker for the axonal and dendritic shafts (Dent & Gertler, 2003), and revealed a large 
expression of both M6 proteins in tubulin rich domains. The co-localization with F-actin, 
which is mainly present in distal regions like growth cones (Dent et al., 2010), proved that 
both proteins are found in F-actin rich compartments. But M6A was notably located at F-actin 
free membrane protrusions. Consequently, M6A and M6B are abundantly expressed in most 
primary cortical neurons and they share a broad distribution, but this is not identical.  
 
 
5.2. M6A defines F-actin free membrane protrusions 
As the localization of M6A had been observed on F-actin free membrane extensions, a more 
profound examination was pursued. Hence, I immunostained primary cortical neurons with 
an antibody against M6A and the F-actin binding toxin phalloidin. Detailed confocal analysis 
including reflection microscopy, allowed analysing the potential co-localization of M6A and F-
actin with the simultaneous confirmation of the outer plasma membrane extension. This was 
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indispensable as it enabled defining the outer membrane of the processes on which M6A 
and F-actin could be confined.  
 
This examination revealed that on many tubular processes (filopodia) M6A and F-actin co-
localize. However, oftentimes M6A has been found on F-actin free membrane extensions 
with intact and continuous membranes. There has been a diversity regarding this partial co-
localization: some tips are M6A and F-actin positive, while the neighbouring one would lack 
F-actin completely, and in some tips the proximal part could be labelled by both, but only 
M6A was found in the distal domains or even just at the distal tip end. Also the length of this 
extension varied, as M6A-positive F-actin-negative processes have been observed to be 
larger than 10 µm. Moreover, this prominent finding is not restricted to tubular processes, but 
has also been observed in flattened membrane extensions. Subsequently, as F-actin has 
been supposed “to compose the core of filopodia” (cited after Dent & Gertler, 2003), M6A 
defines novel F-actin free M6A-rich membrane protrusions.  
 
In the case of M6B, this distinct localization could not be observed. In most membrane tips, 
M6B has been found in the neuronal membrane extension at F-actin-positive domains. Some 
membrane extension lacked both M6B and F-actin, presumably being M6A-positive.  
 
Hence, membrane extensions on cortical neurons express both M6 proteolipids, and M6A 
defines F-actin free membrane protrusions whereas M6B does not.  
 
 
5.3. M6A and M6B are required for growth cone compartmentalization  
Since M6A and M6B had been located extensively on neuronal growth cones (Sheetz et al., 
1990; Baumrind et al., 1992; and current analysis) and especially M6A was found to have a 
very particular localization at F-actin free membrane protrusions, the examination continued 
by analysing the neuronal growth cones in the chronic absence of this proteins. The growth 
cone structure is mainly compartmentalized by MTs being present in the extending axon 
shaft and central growth cone regions, and F-actin concentrated in the peripheral growth 
cone regions, lamellipodia and filopodia (Dent & Kalil, 2001; Dent & Gertler, 2003). Wild-type 
and Gpm6anull*Gpm6bnull cortical neurons were immunostained against tubulin and F-actin. 
 
For the evaluation, initially three categories of tubulin and F-actin localization were 
established, where (1) tubulin and F-actin were overlapping in one compartment, (2) tubulin 
and F-actin were being in two distinct compartments and (3) tubulin was being present at the 
distal domain. Most wild-type cortical neurons, as expected, belonged to the second 
 98
category, with tubulin and F-actin in distinct domains, and tubulin was extremely seldom 
found in the distal regions. Intriguingly, most growth cones of Gpm6anull*Gpm6bnull cortical 
neurons fell into the category of tubulin and F-actin being superimposed. And even 
frequently, growth cones contained tubulin at their most distal domains. In both genotypes, 
this result was consistent no matter the growth cones of the axon or longest neurite or of the 
remaining neurites was assessed.  
 
The comparison was also evaluated after merging the two categories that involved unusual 
tubulin to F-actin localization, as no statistical analysis could be performed with the prior data 
set because of the data points being zero or one in wild-type neurons. This evaluation 
demonstrated significant differences in the distribution of tubulin and F-actin at the growth 
cones. Gpm6anull*Gpm6bnull cortical neurons have frequently tubulin partially superimposed to 
F-actin or even tubulin at the distal end of their growth cones, both on the axon or dendrites, 
while this is not the case for wild-type cortical neurons.  
 
Therefore, the normal F-actin and tubulin compartmentalization in the growth cones of 
Gpm6anull*Gpm6bnull cortical neurons is altered, and this occurred in all process endings, 
either axonal or dendritic. This mislocalization of tubulin and F-actin represents a very 
profound modification of the proper growth cone structure, as the localization of these two 
proteins mainly define distinct morphological and functional growth cone domains. M6A and 
M6B are expressed on most cortical neurons and located throughout the axon, dendrites and 
growth cones, and in their chronic absence, the tubulin to F-actin compartmentalization at the 
growth cones is altered. Hence, the neuronal proteolipids M6A and M6B are required for the 
proper separation of cytoskeletal proteins at the growth cones. 
 
 
5.4. M6A and M6B are required for normal reaction to ephrinA5 
Is there a functional consequence to the altered growth cone compartmentalization? To 
evaluate this, I performed a “growth cone collapse assay” induced by ephrinA5, a well-know 
collapse inducing agent (Knöll et al., 2006) and defined collapse or non-collapse as the 
absence or presence, respectively, of a lamellipodium in the growth cones of the axon or 
longest neurite.  
In wild-type, Gpm6anull and Gpm6bnull single-mutant cortical neurons ephrinA5 induced a 
significant collapse of their growth cones, with the same extend when applying the standard 
or the doubled dose. Surprisingly, the Gpm6anull*Gpm6bnull cortical neurons react differently, 
they react to a much lesser extend at the standard dose. But they undergo a highly 
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significant increase in the abundance of collapsed growth cones when applying the double 
concentration of ephrinA5. 
The present data suggest that although Gpm6anull*Gpm6bnull cortical neurons reacted to an 
ephrinA5 induced “growth cone collapse assay”, they required a greater dose to achieve 
equivalent effects as in the wild-type and the Gpm6anull and Gpm6bnull single-null mutant 
cortical neurons. Thereby, it seemed that M6 proteolipids are important for the proper growth 
cone function. 
 
Another significant difference could be observed when comparing the number of non-
collapsed (defined as presence of a lamellipodium) growth cones in the control group. 
Gpm6anull and even more the Gpm6anull*Gpm6bnull cortical neurons presented a significant 
increased abundance of growth cones with lamellipodia, in comparison to wild-type or 
Gpm6bnull cortical neurons. Therefore, the chronic absence of M6A lead to an increase in the 
number of growth cones presenting lamellipodia. This effect is more pronounced when M6A 
and M6B are missing in the cortical neurons. Once more, these involved the neuronal M6 
proteolipids in the maintenance of the proper growth cone morphology, and thereby function.  
 
To elucidate the reason of the altered responsiveness of Gpm6anull*Gpm6bnull cortical 
neurons to the ephrinA5 induced “growth cone collapse assay”, cortical neuron lysates were 
analysed with immunoblots. To simplify the approach for studying the Eph receptors that 
could bind to ephrinA5, as ephrinA5 binds to EphA1-8 and EphB2 (reviewed by Pasquale, 
2004), the levels of ephexin-1 were assessed, as they relate to the abundance of Eph 
receptors (reviewed by Egea & Klein, 2007). The initial result showed a moderately 
decreased abundance of ephexin-1 in Gpm6anull*Gpm6bnull cortical neurons, when compared 
to wild-type. This would signify a reduction in the overall Eph-receptor levels in the chronic 
absence of M6 proteins, and would thereby be a possible explanation to the altered 
responsiveness of these Gpm6anull*Gpm6bnull cortical neurons in the ephrinA5 induced 
growth cone collapse. 
 
RhoA, as key downstream element acting in growth cones collapse (Wahl et al., 2000; 
reviewed in Hall & Lalli, 2010), was investigated next. Preliminary results showed a slight 
decrease in the RhoA levels in cortical neuron lysates, which would mean that the total levels 
of RhoA would be decreased in the Gpm6anull*Gpm6bnull cortical neurons. Less RhoA could 
account for the delayed reactivity of the Gpm6anull*Gpm6bnull cortical neurons towards the 
ephrinA5 induced growth cone collapse. 
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Thus, the immunoblot analysis provides preliminary results for the significance of M6 proteins 
in growth cone function, potentially by associating to cytoskeleton proteins in lipid rafts and 
thereby regulating the localization and abundance of signalling receptors, like Ephs, and 
signalling proteins, like RhoA.  
 
 
5.5. M6A and M6B are required for neurite outgrowth 
The next step was to assess the functional relevance of the neuronal M6 proteolipids in 
neurite extension, a hallmark in neuronal development. It had been previously demonstrated 
an in vitro involvement of M6A, upon application of the monoclonal M6 antibody against M6A 
(Lagenauer et al., 1992) as well as in overexpression studies (Zhao et al., 2008), in neurite 
outgrowth. For this examination, the neurite length was measured on wild-type, Gpm6anull, 
Gpm6bnull and Gpm6anull*Gpm6bnull cortical neurons, so that the effect of the absence of M6A 
as well as M6B could be assessed.  
 
Interestingly, there is a very significant reduction in neurite length when the M6 proteolipids 
are missing, and this occurs in a gradient manner: from wild-type, to neurons lacking M6B, 
and to neurons lacking M6A or both M6A and M6B. When categorizing the neurons 
according to their neurite extension length, all four genotypes had a significant different 
frequency distribution pattern.  
 
The diminished neurite outgrowth revealed the need of M6 proteins in this important neuronal 
task. The absence of M6B generated a very significant decrease in the neurite length. 
Nevertheless, the neurite extension was even more reduced in the absence of M6A. Hence, 
this suggested an important role of both neuronal M6 proteolipids in the proper neuronal 
development, including neurite extension. 
 
 
5.6. M6A and M6B are required for the response to cholesterol in neurite outgrowth 
Cholesterol is essential for the neuronal function, including the maintenance of the plasma 
membrane and the extension of membrane processes during development (reviewed in 
Benarroch, 2008), plus PLP, ortholog to M6A and M6B, interacts directly with cholesterol 
(Simons et al., 2000; Krämer-Albers et al., 2006), as well as M6B itself (Werner H., pers. 
comm). Therefore, I hypothesized that the impact of the impaired neurite outgrowth in the 
absence of M6 proteins could be related to their potential cholesterol association.  
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To evaluate this, cortical neurons of wild-type and Gpm6anull*Gpm6bnull mice were cultured 
under increasing cholesterol concentrations and their neurite extension was measured. In 
agreement with prior results (Ko et al., 2005), wild-type cortical neurons show a decrease in 
their neurite length upon an increasing cholesterol dose. This confirmed the importance of 
the regulation of the cholesterol levels for proper neuronal function. Unexpectedly, the 
Gpm6anull*Gpm6bnull cortical neurons did not react to the increasing cholesterol amounts and 
preserved their reduced neurite extension (as described above) at the same levels. Even 
under this conditions, which reduced the length of the wild-type neurites, the 
Gpm6anull*Gpm6bnull neurons were still significantly more impaired in their neurite extension 
capacities. 
 
Hence, when cortical neurons lacked chronically M6 proteins they could not respond in the 
normal manner to alterations in the cholesterol concentration. Thus it seemed that M6 




5.7. M6A and M6B are not required for growth cone morphology, adhesiveness and 
motility 
The prior observed differences in growth cone compartmentalization and function, and the 
impaired neurite extension in the chronic absence of neuronal M6 proteins, led to the 
hypothesis of an impaired in vivo behaviour. For that reason, wild-type and 
Gpm6anull*Gpm6bnull cortical neuron growth cones were imaged in vivo with confocal 
reflection microscopy in a short time-frame (10 min), to avoid camouflaging effects of the lack 
of M6 proteins in the overall neurite extension.  
 
When comparing the morphometrical properties like e.g. the perimeter in relation to the total 
growth cone area, as well as the total area itself, no significant differences could be 
observed. Thus, the absence of M6 proteins does not alter the growth cone morphometry in 
a short-time window. The evaluation of the adhesive area in relationship to the total area in 
the growth cones, demonstrated again no significant differences between wild-type and 
Gpm6anull*Gpm6bnull cortical neurons. The adhesiveness was not altered when neuronal 
growth cones lack chronically M6 proteins. As a next step, the motility of the growth cones 
was assessed, by evaluating the retraction and extension between each single image of the 
taken videos. Surprisingly, the motility of growth cones of wild-type and Gpm6anull*Gpm6bnull 
cortical neurons is essentially identical.  
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Thus, unexpectedly, the short-term in vivo analysis of the growth cones of cultured 
Gpm6anull*Gpm6bnull cortical neurons demonstrated similar morphometry, adhesion and 
motility as in wild-type neurons. Therefore, the investigations performed on the ex vivo 
cortical neuron culture system have proven that M6A and M6B are important for several 
aspects of neuronal development, including growth cone compartmentalization and function, 
neurite extension, and the response to the cholesterol levels in neurite extension. But they 
seemed not to be relevant for the short-term morphometry, adhesion and motility. 
 
 
5.8. M6A and M6B are required for proper corpus callosum formation  
To assess if the described alterations of cultured cortical neurons in the chronic absence of 
M6 proteins could be observed in vivo, the corpus callosum of wild-type and 
Gpm6anull*Gpm6bnull mice was analyzed, as it is the largest cortical brain commissure. The 
observed reduced neurite extension, as well as the altered growth cone 
compartmentalization and response to ephrinA5 in Gpm6anull*Gpm6bnull cortical neurons, led 
to the hypothesis of an impaired axonal pathfinding, and thereby a reduction in axons 
crossing the hemispheres at the corpus callosum. So, the corpus callosum width was 
measured at two regions, anterior to the hippocampus and containing the hippocampus.  
 
The comparison of wild-type and Gpm6anull*Gpm6bnull corpora callosa width demonstrated a 
significant reduction of the corpus callosum in Gpm6anull*Gpm6bnull mice. This was found at 
both analyzed levels, although it was even more prominent in the more caudal levels 
comprising the hippocampus. It seemed from prior investigations that in the young adult mice 
no developmental defects could be observed (Fünfschilling U., Werner H., pers. comm.), 
which would argue for a developmental delay in the absence of M6 proteins that is 
compensated throughout development. More detailed analysis in the adult mice should be 
performed, for clarifying if the developmental effect of reduced corpora callosa is actually 
compensated over time.  
 
In the current investigation, M6 proteins seemed to be important for the formation of the 
major white matter tract in the brain, the corpus callosum, thereby being required for the 




5.9. Tetraspanin2 in CNS myelin 
Tetraspanin2 has been shown to be present in CNS compact myelin (Birling et al., 1999) and 
was found to be enriched in PLPnull CNS-enriched myelin fractions by immunoblot analysis 
(Werner H., pers. comm.). Hence, the localization of TSPAN2 was assessed on brain 
sections. TSPAN2 appeared to be present in all white matter tracts in wild-type mice, and to 
some extent in OLs of the gray matter. In the PLPnull mice the levels of TSPAN2 were 
strongly increased, confirming the prior results. TSPAN2 is more abundant in the white 
matter tracts and much more in the OLs of the gray matter. This upregulation of TSPAN2 in 
the absence of PLP suggests that, as both are structurally similar tetraspan proteins found in 




5.10. Targeted inactivation of the murine Tspan2 gene  
The upregulation of TSPAN2 in PLPnull mice and its early onset of expression during OL 
development (Nielsen et al., 2006; Dugas et al., 2006), suggests that TSPAN2 could be a 
relevant protein for CNS myelination. To test this hypothesis, I successfully generated 
TSPAN2null mice by homologous recombination of the murine Tspan2 gene in ES cells. The 
absence of TSPAN2 was proven on the genomic DNA by PCR and on the protein level by 
immunoblot analysis. The TSPAN2null mice breed normally and give rise to offspring with 
genotypes according to the Mendelian inheritance rules. Until known so far, TSPAN2null mice 
showed no obvious phenotypic abnormalities. The fact that there is no obvious phenotype 
could probably be explained by some compensatory mechanism of other myelin 
tetraspanins. Therefore, it would be e.g. interesting to analyze the TSPAN2null*CD9null or the 
TSPAN2null*CD81null mice. 
 
Because the function or at least the abundance of TSPAN2 seemed to be correlating with the 
presence of PLP, TSPAN2null*PLPnull mice were generated by cross-breeding the single-
mutants. These mice were also included in the pursued studies to evaluate the in vivo 
consequence of the chronic lack of these two tetraspan proteins of compact CNS myelin. 
TSPAN2null*PLPnull mice do breed normally and have no obvious phenotypes, as known so 




5.11. Weight increase in TSPAN2null mice 
To evaluate if the normal weight increase does occur during early postnatal development in 
the absence of TSPAN2, the weight increase was measured between P2 and P30 in wild-
type, TSPAN2null, PLPnull and TSPAN2null*PLPnull mice. During this period, TSPAN2null 
weighted similarly to wild-type mice, and both PLPnull and TSPAN2null*PLPnull mice had a 
reduced weight increase. This was also the case when assessing their weight at P30 and at 
ten months of age. Hence, TSPAN2 has no influence on the weight increase during 
development, as well as on the weight in adult mice. The reduced levels in PLPnull and 
TSPAN2null*PLPnull mice probably refer to a minor phenotype in the mice, not yet proven, as 
the weight is related to the overall health of the animals.  
 
 
5.12. Protein composition in TSPAN2null mice 
To assess if the lack of TSPAN2 altered the protein composition of CNS myelin, silver 
staining was performed. These demonstrated no major differences in the protein abundance 
in CNS-myelin enriched fractions, neither at P30 (TSPAN2+/- and TSPAN2null) nor at P75 
(TSPAN2null and TSPAN2null*PLPnull). PLP/DM20 was, as expected, absent in the lack of PLP 
(PLPnull and TSPAN2null*PLPnull).  
 
To perform an examination in more detail, immunoblots on P30 CNS-myelin enriched 
fractions of wild-type, TSPAN2null, PLPnull and TSPAN2null*PLPnull mice were performed. The 
most related myelin tetraspanin to TSPAN2, CD9, did not show, surprisingly, any abundance 
difference. This was an unexpected result, as CD9 was the primary candidate to potentially 
compensate for the absence of TSPAN2, as both are very similar structurally and are found 
in the same domains of CNS myelin (Birling et al., 1999; Ishibashi et al., 2004). However, the 
abundance of the myelin tetraspanin CD81, the next close related tetraspanin (Garcia-
España et al., 2008), was augmented in TSPAN2null, PLPnull and TSPAN2null*PLPnull mice. And 
the smaller isoform is additionally increased in PLPnull and TSPAN2null*PLPnull. Therefore, 
CD81 does seem to compensate for TSPAN2. The myelin tetraspanins CD82 and CD63 
revealed no differences at all. CD82 has been involved in the early stages of OL 
development (Mela & Goodman, 2009) and possibly its abundance levels could be regulated 
at earlier postnatal stages. CD63 is known to be in CNS myelin (Baer et al., 2009), but until 
now, the investigations have related CD63 mainly to exosomes and late lysosomes 
(reviewed in Pols & Klumperman, 2008) and it is unknown if CD63 is actually present at the 
compact CNS myelin. The two CNS myelin tetraspanins, CD151 and OAP-1 could not be 
assessed while performing this characterization. CD151 is an important regulator of cell 
morphology in an integrin-dependent manner (reviewed in Hemler, 2005), but there is no 
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evidence of its exact localization in the CNS myelin domains, as well as its function in the 
nervous system. And OAP-1 has been involved in OL proliferation (Tiwari-Woodruff et al., 
2001). It is very tempting to suggest that these two, CD151 and OAP-1, that are known to 
bind integrins (a typical characteristic of tetraspanins, Hemler, 2005), could compensate for 
the lack of TSPAN2 in the CNS myelin. Further investigation should assess this interesting 
question.  
 
In addition, the abundance of Fyn, a tyrosine kinase important in OL maturation (reviewed in 
Krämer-Albers & White, 2011) was also not altered. This was, yet again, an unexpected 
result, as tetraspanins assemble signalling molecules and Fyn was a major candidate to be 
regulated by TSPAN2.  
 
Beside, the non-compact myelin protein CNP has also no different abundance levels in the 
absence of TSPAN2 at P30 and at P75. However, the MBP levels demonstrated a notably 
augmented abundance in the CNS-myelin enriched fractions of TSPAN2null, PLPnull, and 
TSPAN2null*PLPnull mice. And in the latter two, the abundance of the larger isoform was as 
well increased. MBP is the second most abundant compact myelin protein and it is involved 
in myelin compaction and is essential for myelination (reviewed in Boggs, 2006). The 
augmented MBP levels suggested a compensation for an altered compaction in TSPAN2null, 
PLPnull, and TSPAN2null*PLPnull mice. This would be in accordance to the prior knowledge of 
PLPnull mice having a reduced CNS myelin compaction (Klugmann et al., 1997). This 
unexpected and promising result should be assessed in more detail, for understanding the 
manner TSPAN2 and MBP do possibly interact.  
 
Therefore, an obvious abundance difference was found regarding MBP, which is strongly 
increased in the absence of TSPAN2, at P30 and at P75. MBP could compensate for a 
reduced CNS compaction in the TSPAN2null mice. And it is the tetraspanin CD81 that 
seemed to compensate for the lack of TSPAN2. This altered regulation of MBP and CD81 







6. Summary and conclusions 
The neuronal tetraspan proteolipids M6A and M6B were previously characterized regarding 
their cellular expression, and by acute manipulation in vitro. However, little was known of 
their function during neuronal development in vivo. I have analysed primary cortical neurons 
of mice chronically lacking M6A, M6B, or both. The absence of M6-proteins led to an altered 
morphology of the axonal growth cones regarding actin/tubulin compartmentalization, and an 
augment in growth cones with lamellipodia. The latter feature was also apparent in growth 
cones lacking only M6A. Interestingly in this regard, M6A defines an F-actin free 
subcompartment of the growth cone filopodia. Importantly, M6-deficient growth cones did not 
collapse normally upon the application of the known collapsing agent ephrinA5, which can be 
explained by the finding that the abundance of the Eph-receptor signalling-mediator ephexin1 
is reduced in cortical neurons devoid of M6-proteolipids. By live-cell imaging I could assess 
that chronic lack of M6-proteins does not impair the normal adhesiveness or motility of 
neuronal growth cones. Nevertheless, cortical neurons lacking M6 proteins were impaired 
regarding neurite outgrowth, which cannot be ameliorated by the addition of cholesterol. In 
vivo, there is a reduced width of the corpus callosum, which connects most cortical areas of 
the two brain hemispheres, in GPM6Anull*GPM6Bnull double null mutant mice, at least during 
early postnatal development. Together, M6 proteins are required for normal growth cone 
morphology and function and for neurite outgrowth, but not for normal growth cone motility.  
 
The third member of the proteolipid protein family is proteolipid protein (PLP), the most 
abundant constituent of CNS myelin. Mice and humans lacking PLP are largely normally 
myelinated, which has been difficult to explain. In a candidate approach the low-abundant 
myelin tetraspan tetraspanin-2 (TSPAN2) has been identified as a candidate to compensate 
for PLP-deficiency because of its dramatically increased abundance in PLP-deficient myelin. 
To investigate the role of TSPAN2 in myelination, I generated TSPAN2null mutant mice by 
homologous recombination in embryonic stem cells. These mice are viable, breed normally 
and the initial evaluation at the protein level shows several alterations. The abundance of the 
closely related tetraspanin CD81 as well as that of the major myelin protein MBP is increased 
in myelin isolated from TSPAN2null mice, indicating molecular changes that may compensate 
for the absence of TSPAN2 function. Therefore, TSPAN2 seems to play a role at the 
oligodendrocyte early development. Further investigations will be necessary to elucidate the 
molecular mechanisms of how TSPAN2 acts during myelin biogenesis.  
 
Together, structurally related tetraspan proteins, including the neuronal proteolipids M6A and 
M6B, and the oligodendroglial PLP and TSPAN2, are required for the normal formation of 
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